<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3430,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/bd5ce10409fb087e0c3197a78cab0775'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/bd5ce10409fb087e0c3197a78cab0775'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1HPBTO003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HPBTO003">Previous Result: <span>Baker v. Colorado, Civil Action No. 11-c...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1HPBTQ003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HPBTQ003">Next Result: <span>A.H . v. Evenflo Co., Civil Action No. 1...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion'>
Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion</div>
<div class='docId'>X1HPAH4003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Merial Ltd. v. Cipla Ltd.</div>
<div class='displayCitation'>103 U.S.P.Q.2d 1001</div>
<div class='displayCitation'>2012 BL 132909</div>
<div class='displayCitation'>681 F.3d 1283</div>
<div class='displayCitation'>bna a0d2v0h6t2</div>
<div class='displayCitation'>bna a0d3e6h0y1</div>
<div class='displayCitation'>wkffecase:26105106</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HPAH4003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Merial Ltd. v. Cipla Ltd." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1HPAH4003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HPAH4003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HPAH4003" /><input id="title" name="title" type="hidden" value="Merial Ltd. v. Cipla Ltd., 681 F.3d 1283, 103 U.S.P.Q.2d 1001 (Fed. Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="bd5ce10409fb087e0c3197a78cab0775" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HPAH4003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="true" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Fbd%35ce%31%30%34%30%39fb%30%38%37e%30c%33%31%39%37a%37%38cab%30%37%37%35%2Fdocument%2FX%31HPAH%34%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/bcite/X1HPAH4003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/bcite/X1HPAH4003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/bcite/X1HPAH4003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/related_content/X1HPAH4003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1710824226819";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,ReporterOfDecisions,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">681 F.3d 1283</div>
<div class="cite" data-cite-type="ReporterOfDecisions">103 U.S.P.Q.2d 1001</div>
<div class="cite" data-cite-type="DocketNumber">Nos. 2011-1471, 2011-1472.</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 132909</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">U.S.P.Q.2d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">***</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Federal Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
MERIAL LIMITED and Merial Sas, Plaintiffs-Appellees, and BASF Agro
B.V., Plaintiff, v. CIPLA LIMITED, Defendant-Appellant, and Velcera, Inc.
and Fidopharm, Inc., Defendants-Appellants, and Archipelago Suppliers,
Arrowtarget Enterprises Ltd., Generic Petmeds, In-house Drugstore, Lisa
Perko, Petcare Pharmacy, and Petmeds R Us, Defendants.
</center></p>
<hr align="center" width="65%">
<p><center>
Nos. 2011-1471, 2011-1472.
</center></p>
<p><center>
May 31, 2012.
<span CLASS="page_no" data-cite="103 uspq 2d 1004" data-cite-type="ReporterOfDecisions" data-cite-pageno="1004" data-primary-citation="103 U.S.P.Q.2d 1001">[**1004]</span> </center></p>
<div class="headnotesToggle clearfix"><button id="toggle_headnotes_button" class="bootstrap skinButton sourceButton wide right hideSource" data-target="#headnotes_container"><span>Hide Headnotes</span></button></div>
<div class="headnotesContainer" id="headnotes_container">
<div class="headnotesContainerTitle">BNA Headnotes</div>
<div class="headnoteTitle"><a href="http://www.bloomberglaw.com/document/1475619602000128">U.S. Patents Quarterly</a></div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">JUDICIAL PRACTICE AND PROCEDURE</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917883" href="#headnote_ref_pq2-dec_917883">[1]</a> <span>Jurisdiction &mdash; Personal jurisdiction </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=405.11" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="405.11">&#9658;405.11</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_1" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_1" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Jurisdiction &mdash; Service of process &mdash; Long arm statutes </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=405.1303" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="405.1303">&#9658;405.1303</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_2" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_2" class="headnoteContent"></div>
<div class="headnote_text">
Federal district court in Georgia properly exercised personal jurisdiction over defendant foreign company, under Fed. R. Civ. P. 4(k)(2), in entering default judgment and injunction against defendant in patent infringement action, since application of Rule 4(k)(2) requires finding that defendant has sufficient contacts with United States as whole to satisfy due process standards, but is not subject to personal jurisdiction of courts in any single state, since defendant challenging prior default judgment cannot do so by naming another forum that would not have had independent basis for jurisdiction at time of original complaint, and since defendant contends that it would have been subject to personal jurisdiction in Illinois based on expected collaboration with Illinois corporation, but its evidence does not show any resulting contacts with Illinois, shipments of accused products to Illinois, or revenue or sales generated in Illinois before plaintiffs filed suit in present case.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917884" href="#headnote_ref_pq2-dec_917884">[2]</a> <span>Jurisdiction &mdash; Service of process &mdash; In general </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=405.1301" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="405.1301">&#9658;405.1301</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_3" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_3" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Judicial review &mdash; Appealability </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.4603" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.4603">&#9658;410.4603</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_4" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_4" class="headnoteContent"></div>
<div class="headnote_text">
Patent infringement defendant appealing from judgment holding it in contempt for violation of permanent injunction waived argument that service of process on it was legally deficient, since defendant has raised its argument for first time on appeal, even though argument could have been, but was not, presented in its motion to vacate default judgment and injunction pursuant to Fed. R. Civ. P. 60(b)(4).</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917885" href="#headnote_ref_pq2-dec_917885">[3]</a> <span>Jurisdiction &mdash; Personal jurisdiction </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=405.11" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="405.11">&#9658;405.11</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_5" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_5" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Jurisdiction &mdash; Service of process &mdash; Long arm statutes </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=405.1303" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="405.1303">&#9658;405.1303</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_6" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_6" class="headnoteContent"></div>
<div class="headnote_text">
Parties in most cases may satisfy federal pleading standards by alleging personal jurisdiction generally, without asserting specific basis for personal jurisdiction over defendant, and Fed. R. Civ. P. 4(k)(2) can be considered even if plaintiff has affirmatively pleaded different basis for personal jurisdiction; in present case, federal district court's exercise of personal jurisdiction over defendant foreign company under Rule 4(k)(2) in patent infringement action is affirmed, even though complaint did not mention Rule 4(k)(2), and district court, before determining that defendant was subject to personal jurisdiction under Rule 4(k)(2), found that record did not show sufficient contacts with forum for defendant to be subject to personal jurisdiction under forum's long-arm statute, since defendant had actual notice of suit and chose to risk default judgment by declining to answer, based on its subjective assessment of complaint and despite existing precedent that Rule 4(k)(2)
could apply whether or not it was raised by parties, since defendant chose not to file pre-answer motion under Rule 12(b)(2) to settle all personal jurisdiction issues up front, and since defendant had full opportunity to litigate personal jurisdiction during subsequent contempt proceedings, and having lost on that issue, cannot now insist that default judgment must nonetheless be vacated because basis for jurisdiction alleged in complaint differed from basis ultimately relied on by district court.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917886" href="#headnote_ref_pq2-dec_917886">[4]</a> <span>Procedure &mdash; Stays &mdash; In general </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.2901" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.2901">&#9658;410.2901</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_7" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_7" class="headnoteContent"></div>
<div class="headnote_text">
Denial of defendant's request for stay of contempt proceedings in patent infringement suit pending resolution of &ldquo;parallel&rdquo;
declaratory judgment action in another forum is affirmed, even though complaint in declaratory judgment case was filed some six weeks before plaintiffs moved to hold defendants in contempt in infringement action, since complaint in infringement action was filed before complaint in declaratory judgment suit, and federal district court thus correctly viewed contempt proceedings as first-filed, and since, even if declaratory action could be considered first suit filed, district court was well within its discretion in concluding that principles of comity would not support stay, in that precise issues at stake differed between proceedings, and key party was absent from declaratory action.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917887" href="#headnote_ref_pq2-dec_917887">[5]</a> <span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_8" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_8" class="headnoteContent"></div>
<div class="headnoteSlug">JUDICIAL PRACTICE AND PROCEDURE</div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Parties; standing </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.07" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.07">&#9658;410.07</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_9" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_9" class="headnoteContent"></div>
<div class="headnote_text">
Defendant importers of accused veterinary pharmaceuticals are properly subject to judgment holding them in contempt for violation of permanent injunction, even though they were not parties to original proceedings, in which default judgment and injunction was entered against codefendant manufacturer, since importers, as unsolicited intervenors in contempt proceedings, joined suit subject to all determinations of fact and law that preceded their intervention, and since, for purposes of litigation, default judgment established, among other things, that patent in suit was not invalid and was infringed by manufacturer's product.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917888" href="#headnote_ref_pq2-dec_917888">[6]</a> <span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_10" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_10" class="headnoteContent"></div>
<div class="headnote_text">
Federal district court's colorable-differences analysis underlying its finding of contempt in action for infringement of patent for veterinary medicine rested on affirmatively judged infringing features of first accused product, even though original infringement finding was established through default judgment, since judgment based on infringement established through default is no less binding or authoritative simply because comprehensive and painstaking factual analyses regarding every claim limitation may have been unnecessary or impractical at time of initial decision, and thus default order in present case, whether or not it included exhaustive infringement analysis, necessarily and conclusively established that original accused product met each limitation in asserted claims, and since evidence presented during contempt proceedings provided ample basis for concluding that newly accused product is not more than colorably different from original infringing product.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917889" href="#headnote_ref_pq2-dec_917889">[7]</a> <span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_11" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_11" class="headnoteContent"></div>
<div class="headnote_text">
Finding that product newly accused in contempt proceedings infringes patent for veterinary medicine is affirmed, even though federal district court compared accused product to plaintiffs'
product, since it is undisputed that patent covers plaintiffs' product, since there is no blanket prohibition against comparing accused product to commercial embodiment in infringement analysis, and such approach is appropriate in summary contempt proceeding if it is especially convenient or expeditious, and benchmark product represents recognized embodiment of patent in suit, and since district court considered undisputed evidence that accused product contains precisely same concentrations of ingredients for protecting pets from flea and tick infestations as plaintiffs' product, and that those concentrations constitute synergistically effective amounts as recited in claims, as well as testimony by CEO of defendant importer admitting that, if patent in suit is valid, then accused product infringes.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917890" href="#headnote_ref_pq2-dec_917890">[8]</a> <span>Infringement &mdash; Inducement </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.15" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.15">&#9658;120.15</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_12" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_12" class="headnoteContent"></div>
<div class="headnote_text">
Conduct by which foreign party, with requisite knowledge and intent, employs extraterritorial means to actively induce acts of direct infringement that occur within United States is not categorically exempt from redress under 35 U.S.C. &sect;271(b), which does not, on its face, foreclose liability for such extraterritorial acts.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917891" href="#headnote_ref_pq2-dec_917891">[9]</a> <span>Infringement &mdash; Inducement </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.15" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.15">&#9658;120.15</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_13" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_13" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_14" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_14" class="headnoteContent"></div>
<div class="headnote_text">
Foreign defendants' layered contractual arrangements and elaborate distribution chain for infringing veterinary pharmaceutical product do not preclude finding that defendants should be held in contempt for violation of permanent injunction entered in infringement suit, since defendants' overseas activities are not necessarily outside scope of injunction, which prohibits not only direct infringement, but also any act that &ldquo;causes or induces infringement&rdquo;
of patent in suit, and since it is therefore unnecessary to determine whether defendant manufacturer exerted control over allegedly independent actions of nonparty intermediary companies, in that manufacturer's own extraterritorial conduct can violate injunction as indirectly infringing under 35 U.S.C. &sect;271(b).</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917892" href="#headnote_ref_pq2-dec_917892">[10]</a> <span>Infringement &mdash; Inducement </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.15" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.15">&#9658;120.15</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_15" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_15" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_16" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_16" class="headnoteContent"></div>
<div class="headnote_text">
Judgment that foreign defendant manufacturer violated permanent injunction by inducing infringement of patent in suit is affirmed, since district court explicitly found that product newly accused in contempt proceeding infringes patent, that defendant importers sold infringing product in United States, that manufacturer and importers were aware of patent and injunction, that manufacturer played fundamental roles in manufacturing, packaging, and assisting in development of infringing product for importers to sell in United States, that manufacturer knew infringing product was to be sold in United States, and that manufacturer knew and intended that such sales would infringe patent, and since those findings bear directly on question of inducement and are not clearly erroneous; district court's finding that manufacturer &ldquo;caused an infringing product to be sold in the United States&rdquo; in direct violation of injunction does not signal application of incorrect standard for inducement, since contempt order simply reflects language of injunction itself, which is central to contempt analysis and uses terms &ldquo;cause&rdquo; and &ldquo;induce&rdquo;
interchangeably to describe prohibited indirectly infringing conduct.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917893" href="#headnote_ref_pq2-dec_917893">[11]</a> <span>Infringement &mdash; Contempt proceedings </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.17" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.17">&#9658;120.17</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_17" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_17" class="headnoteContent"></div>
<div class="headnote_text">
Federal district court did not clearly err by finding defendant importers in contempt for working &ldquo;in active concert or participation&rdquo; with defendant foreign manufacturer to violate injunction entered in action for infringement of patent for veterinary medicine, even though importers were not party to default judgment entered against manufacturer, since persons or entities not party to litigation may be held in contempt if they act in concert with enjoined party to assist in violating soundly issued injunction, since defendant importers admitted that by time of their infringing acts, they were aware of patent in suit, knew accused product would infringe patent, and had notice of injunction against defendant manufacturer, and since district court, in concluding that importers worked in active concert with manufacturer with common aim of evading injunction, clearly contemplated structure of importers' interactions with manufacturer, and appreciated and accepted importers' account regarding formal and legal business relationships behind infringing product.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">REMEDIES</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_917894" href="#headnote_ref_pq2-dec_917894">[12]</a> <span>Non-monetary and injunctive &mdash; Equitable relief &mdash;
Permanent injunctions &mdash; Patents </span> <a href="http://www.bloomberglaw.com/document/1710824226819/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=505.0709.07" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="505.0709.07">&#9658;505.0709.07</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_18" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_18" class="headnoteContent"></div>
<div class="headnote_text">
Issuance of injunction in contempt order permanently enjoining sales of infringing veterinary pharmaceutical is affirmed, even though defendant manufacturer argues that injunction would have crippling effect on its business, since party that builds business on product found to infringe cannot complain that injunction against continuing infringement will destroy that business, and since district court did not clearly err in finding that introduction of infringing product as generic alternative to plaintiffs' product would result in considerable lost market share and price erosion, thus favoring entry of injunction, particularly in view of evidence that defendants' marketing strategy specifically targeted plaintiffs' product by touting infringing product as cheaper but otherwise equal alternative.</div>
</div>
</div>
<script type="text/javascript">
					jQuery(function($) {
						$('#toggle_headnotes_button').click(document_toggleHeadnoteVisibility);
					});
				</script><div id="para2" printdualcolumn="true"><p>
  Appeal from the United States District Court for the Middle
District of Georgia, Clay D. Land, J.
</p></div>
<span CLASS="page_no" data-cite="681 f 3d 1284" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1284" data-primary-citation="681 F.3d 1283">[*1284]</span> <div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="681 f 3d 1285" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1285" data-primary-citation="681 F.3d 1283">[*1285]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="681 f 3d 1286" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1286" data-primary-citation="681 F.3d 1283">[*1286]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="681 f 3d 1287" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1287" data-primary-citation="681 F.3d 1283">[*1287]</span> 
</p></div>
</div>
<div id="para2" printdualcolumn="true"><p>
  Gregory A. Castanias, Jones Day, of Washington, DC, argued
for the plaintiffs-appellees. With him on the brief were Damon
M. Lewis; and J. Patrick Elsevier, of San Diego, CA. Of counsel
on the brief were Judy Jarecki-Black, Merial Limited, of
Duluth, Georgia, Frank G. Smith, III, Alston &amp; Bird, LLP,
of Atlanta, GA, and Edward Donald Tolley, Cook, Noell, Tolley,
Bates &amp; Michael, LLP, of Athens, GA.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Nagendra Setty, Sheppard, Mullin, Richter &amp; Hampton LLP, of
San Francisco, CA, argued for defendant-appellant Cipla
Limited. Of counsel were Paul Wendell Garrity and Mark Edward
McGrath, of New York, NY.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Jonathan G. Graves, Cooley LLP, of Reston, VA, argued for
defendants-appellants FidoPharm, Inc., et al. With him on the
brief were Phillip E. Morton; and Tryn T. Stimart, of
Washington, DC. Of counsel was Lori R. Mason, of Palo Alto, CA.
Of counsel on the brief were George C. Lombardi, Winston
&amp; Strawn LLP, of Chicago, IL; and Elizabeth P. Papez, of
Washington, DC.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Before LOURIE, SCHALL, and REYNA, Circuit Judges.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Opinion for the court filed by Circuit Judge LOURIE.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Dissenting opinion filed by Circuit Judge SCHALL.
<span CLASS="page_no" data-cite="681 f 3d 1288" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1288" data-primary-citation="681 F.3d 1283">[*1288]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  LOURIE, Circuit Judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cipla Ltd. ("Cipla") joins with Velcera, Inc. and
FidoPharm, Inc. (collectively, "Velcera") in appealing from a
judgment entered by the United States District Court for the
Middle District of Georgia in favor of Merial Ltd. and Merial
SAS (collectively, "Merial") holding Cipla in contempt for
violating an earlier injunction and holding Velcera in contempt
for acting in concert with Cipla to violate that injunction.
<i>Merial Ltd. v. Cipla Ltd.</i>, No. <cite>3:07-CV-125 (CDL)</cite>,
[<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 U.S. Dist. LEXIS 65639, <a>2011 WL 2489753</a> (M.D.Ga. June 21, 2011)
("<i>Contempt Order</i>"). For reasons set forth below, we
<i>affirm</i> the district court's judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               BACKGROUND
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                  <i>The Patented Pest Control Technology</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This appeal concerns patented compositions for protecting
domestic dogs and cats from infestation with ectoparasites,
<i>e.g.</i>, fleas and ticks. In particular, the dispute
centers on topically applied or "spot on" veterinary
compositions containing pesticidal N-phenylpyrazole
derivatives, such as fipronil, applied directly to the skin of
an animal. BASF's <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">U.S. Patent 5, 232, 940</a> ("the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940
patent</a>"), now expired, claimed fipronil and fipronil-based
compositions as well as methods <span CLASS="page_no" data-cite="2012 bl 132909 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[***2]</span> of using such compositions for
pest control. Merial, as the exclusive licensee of the
&prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940 patent</a>, developed commercially successful spot-on
fipronil compositions sold under the brand name Frontline.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition to producing fipronil-only products, Merial devised
dual-acting pest control compositions covered by <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">U.S. Patent 6,
096,329</a> ("the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>"). In particular, the
&prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a> claims spot-on compositions containing
fipronil combined with a second active ingredient &mdash;
specifically, an insect growth regulator ("IGR"). In contrast
to pesticides, which work through direct toxicity, IGRs act not
by killing individual parasites but rather by interrupting the
life cycle within a parasite population. The &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>
discloses numerous IGRs &mdash; such as methoprene, for example
&mdash; that mimic natural insect hormones to prevent immature
or juvenile-stage parasites from reaching reproductive
maturity, thereby limiting and eventually depleting an
infestation. In the pesticide-plus-IGR compositions disclosed
in the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>, the paired active ingredients
complement one another through their distinct methods of action
to achieve improved pest protection relative to either agent
administered alone. Merial markets compositions combining
fipronil and methoprene as Frontline Plus, the leading
veterinary <span CLASS="page_no" data-cite="103 uspq 2d 1005" data-cite-type="ReporterOfDecisions" data-cite-pageno="1005" data-primary-citation="103 U.S.P.Q.2d 1001">[**1005]</span> flea and tick treatment in the United States.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                        <i>The 2008 Default Judgment</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cipla is a pharmaceutical company incorporated under the laws
of India with its principal place of business in Mumbai, India.
In November 2007, Merial filed suit against Cipla and various
internet retailers in the United States District Court for the
Middle District of Georgia alleging infringement of the
&prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940</a> and &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patents</a> ("the 2007 complaint").
Merial alleged that Cipla was subject to personal jurisdiction
in the district court by virtue of Cipla's alleged contacts
with and conduct within the state of Georgia, and Merial
provided Cipla with service of process in Mumbai by courier and
registered mail. According to the 2007 complaint, Cipla and the
defendant online retailers sold throughout the United States
spot-on veterinary pesticide products known as "Cipla
Protektor" and "Cipla Protektor Plus" that constituted
infringing formulations of fipronil or fipronil and methoprene,
respectively.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Neither Cipla nor any of the other defendants responded to the
2007 complaint
<span CLASS="page_no" data-cite="681 f 3d 1289" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1289" data-primary-citation="681 F.3d 1283">[*1289]</span> 
or entered an appearance in the district court. Merial
therefore moved to hold the defendants in default pursuant to
Federal Rule of Civil Procedure <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L4A003?jcsearch=Federal%20Rule%20of%20Civil%20Procedure%2055&amp;summary=yes#jcite">55</a>, and the district court
granted that motion on March 6, 2008. In relevant part, the
district court found that the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940</a> and &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patents</a>
were not invalid, found that Cipla had infringed each patent,
and entered a permanent injunction barring Cipla from directly
or in-directly infringing the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940</a> or &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patents</a>
in the future:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  [Cipla], as well as those persons and entities in
  active concert with [Cipla] who have notice of this
  order, are here-with permanently enjoined from
  committing any act that infringes or causes <span CLASS="page_no" data-cite="2012 bl 132909 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[***3]</span> or induces
  infringement of any claim of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940</a> or
  &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patents</a>, including but not limited to
  making, having made, using, causing to be used,
  selling, causing to be sold, offering for sale, and
  causing to be offered for sale in the United States,
  and importing and causing to be imported into the
  United States, any product that infringes any claim of
  the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2GGC49200J?jcsearch=usp%205232940&amp;summary=yes#jcite">940</a> or &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patents</a>, including but
  not limited to the veterinary products denominated
  CIPLA PROTEKTOR that contain fipronil and the products
  denominated CIPLA PROTEKTOR PLUS that contain fipronil
  and methoprene.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>BASF Agro B.V. v. Cipla Ltd.</i>, No. <cite>3:07-CV-125 (CDL)</cite>
(M.D.Ga. Mar. 6, 2008), ECF No. 18, slip op. at 2-3
("<i>Default Order</i>"). On April 14, 2008, Cipla filed in
the court an "informal" communication that referenced the
default proceedings but was "not intended to constitute an
appearance," in which Cipla denied infringing or having "any
presence in the United States and in this judicial district"
and requested dismissal of the action. J.A. 1130-31. The
district court denied Cipla's request for such "informal
equitable assistance" and entered final judgment on April 15,
2008. <i>BASF Agro B.V. v. Cipla Ltd.</i>, No. <cite>3:07-CV-125
(CDL)</cite> (M.D.Ga. Apr. 15, 2008), ECF Nos. 22, 23.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                        <i>The PetArmor Plus Venture</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Velcera was formed in 2004 to develop veterinary
pharmaceuticals for companion animals such as dogs and cats,
beginning with products for inhalation-based drug delivery. Led
by former Merial executives, Velcera later began preparations
to enter the market for flea and tick control products. In
particular, Velcera intended to introduce products that would
"directly compete"-with Merial's Frontline series "at a
substantially lower price." J.A. 2222. Through its relationship
with a two-person British company known as Omnipharm Ltd.
("Omnipharm"), Velcera engaged with Cipla to develop, test,
manufacture, and distribute such products, and by April 2011
those efforts culminated in U.S. sales of spot-on pest control
compositions containing fipronil and methoprene &mdash; sold as
PetArmor Plus and Velcera Fipronil Plus (collectively,
"PetArmor Plus") &mdash; that prompted the contempt proceedings
at issue in this appeal. <i>See</i> J.A. 2222-27. We now
briefly recount the roles played by each of the principal
entities, and their many subsidiaries, in the development and
production of PetArmor Plus.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In February 2008, Velcera established FidoPharm as its wholly
owned subsidiary, and, on the same day, FidoPharm executed a
license and development agreement with Omnipharm under which
Omnipharm would develop the PetArmor Plus formulations and
license those formulations exclusively to FidoPharm for sale in
the United States. J.A. 2225-26. In addition, the license and
development agreement between FidoPharm and Omnipharm
identified Cipla as the intended manufacturer of PetArmor Plus.
<i><cite>Id</cite>.</i> FidoPharm simultaneously entered into a separate
manufacture and supply agreement with QEDetal Ltd. ("QEDetal")
&mdash; an Irish entity held entirely
<span CLASS="page_no" data-cite="681 f 3d 1290" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1290" data-primary-citation="681 F.3d 1283">[*1290]</span> 
by <span CLASS="page_no" data-cite="103 uspq 2d 1006" data-cite-type="ReporterOfDecisions" data-cite-pageno="1006" data-primary-citation="103 U.S.P.Q.2d 1001">[**1006]</span> the director of Omnipharm and established through a
collaboration between Omnipharm and Cipla. J.A. 2225; 4859-60.
Under that agreement, <span CLASS="page_no" data-cite="2012 bl 132909 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[***4]</span> QEDetal would supply FidoPharm with
finished PetArmor Plus products for importation and sale within
the United States. FidoPharm was to submit orders and payments
to QEDetal, QEDetal would then direct Cipla to produce and
deliver sufficient product to fulfill FidoPharm's order, and
finally QEDetal would transfer the finished PetArmor Plus to
FidoPharm. J.A. 2225-26.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Like Velcera, Cipla entered into its own set of parallel
development and supply agreements with Omnipharm and QEDetal,
respectively, in April 2008. Under its development agreement
with Omnipharm, Cipla agreed to conduct laboratory testing and
otherwise assist in the development and regulatory approval of
the PetArmor Plus formulations. J.A. 2226. In addition, Cipla's
manufacture and supply agreement with QEDetal specified that
Cipla would satisfy QEDetal's requirements for fulfilling
PetArmor Plus orders placed by FidoPharm pursuant to the
FidoPharm/QEDetal manufacture and supply agreement. <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In practice, the parties' interrelated web of agreements and
intermediaries involved in producing and distributing PetArmor
Plus functioned as follows: Velcera (through FidoPharm) would
place an order for PetArmor Plus with Omnipharm, which would
then pass the order to Cipla. Upon producing the product in
India, Cipla would transfer ownership of the new PetArmor Plus
to QEDetal LZE, <a HREF="#fn100" name="fnref_fn100">[fn1]</a> which would in turn ship the product from
India to Dubai and there transfer title to QEDetal. Formal
ownership of the product would transfer yet again in Dubai,
from QEDetal to FidoPharm, and, finally, FidoPharm would import
the PetArmor Plus for sale in the United States. Monetary
consideration for each order would flow from FidoPharm to Cipla
along a reciprocal path that mirrored the product supply chain.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With their contractual agreements in place, Velcera, Cipla, and
Omnipharm worked to develop PetArmor Plus and secure regulatory
approval in the United States. Through FidoPharm, Velcera
worked with Omnipharm to design the PetArmor Plus formulation
and directed Cipla to manufacture and test candidate
formulations in India. In addition, Velcera established
LoradoChem, Inc. ("LoradoChem") as a wholly-owned subsidiary of
Velcera's wholly-owned FidoPharm subsidiary to file the
regulatory applications necessary for approval to import and
sell PetArmor Plus in the United States. LoradoChem prepared
and submitted to the United States Environmental Protection
Agency ("EPA") an "Identical/Substantially Similar Product"
pesticide registration application, which facilitates expedited
registration for products that are substantially similar or
identical to a previously registered pesticide formulation. See
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEGRMQ003?jcsearch=7%20U.S.C.%20%20136a(c)(3)(B)&amp;summary=yes#jcite">7 U.S.C. &sect; 136a</a>(c)(3)(B). In communications with the EPA,
LoradoChem identified PetArmor Plus as "identical or
substantially similar" to Merial's previously registered
Frontline Plus products and submitted experimental data
generated by Cipla to support that assertion. Indeed, those
data showed that PetArmor Plus contains the same concentrations
<span CLASS="page_no" data-cite="2012 bl 132909 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[***5]</span> of fipronil and methoprene as Frontline Plus. As required by
the EPA, LoradoChem also submitted Cipla's EPA establishment
number 87688-IND-01 with its application, identifying Cipla as
the sole manufacturer of PetArmor Plus. In view of LoradoChem's
submissions, the EPA approved PetArmor Plus for pesticide
registration
<span CLASS="page_no" data-cite="681 f 3d 1291" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1291" data-primary-citation="681 F.3d 1283">[*1291]</span> 
as identical/substantially similar to Front-line Plus on
January 10, 2011.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Soon thereafter, PetArmor Plus production began. Upon request,
Cipla manufactured each unit of PetArmor Plus for delivery to
QEDetal, transfer to QEDetal LZE and FidoPharm, and eventual
importation into the United States. Cipla supplied PetArmor
Plus in finished, market-ready condition, with the pesticide
formulation provided in single-dose pipettes and enclosed in
its final retail packaging. Cipla's PetArmor Plus packaging
included Cipla's EPA establishment number, as required for all
pesticide products sold in the United States, as well as U.S.
telephone numbers promising 24-hour customer support. An
exemplary unit of PetArmor Plus, finished and ready for sale,
is depicted below:
<span CLASS="page_no" data-cite="103 uspq 2d 1007" data-cite-type="ReporterOfDecisions" data-cite-pageno="1007" data-primary-citation="103 U.S.P.Q.2d 1001">[**1007]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1HPAH4003?documentName=69144_a">Exhibit</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Br. Appellee at 43. The first shipments of PetArmor Plus
arrived in the United States in March 2011 and were offered for
sale the following month.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                      <i>The 2011 Contempt Proceedings</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having become aware of Cipla's role in the impending commercial
launch of PetArmor Plus, Merial filed a motion for contempt in
the United States District Court for the Middle District of
Georgia on March 28, 2011 (the "contempt proceedings"). J.A.
1135-54. Merial contended that Cipla's activities relating to
PetArmor Plus violated that court's 2008 injunction against
infringement of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>.<a HREF="#fn200" name="fnref_fn200">[fn2]</a> In particular,
Merial alleged that PetArmor Plus was no more than a rebranded
version of Cipla's enjoined Protektor Plus product and that the
importation and sale of PetArmor Plus within the United States
therefore violated the injunction. Velcera moved to intervene
in the contempt proceedings as an interested party on April 8,
2011, and was promptly joined as a defendant and ordered to
show cause why it should not be held in contempt for acting
<span CLASS="page_no" data-cite="681 f 3d 1292" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1292" data-primary-citation="681 F.3d 1283">[*1292]</span> 
in concert with Cipla to contravene the 2008 injunction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Meanwhile, Velcera had filed a declaratory judgment complaint
against Merial in the United States District Court for the
District of Delaware on February 11, 2011, alleging
noninfringement and invalidity of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a> (the
"Delaware action").<a HREF="#fn300" name="fnref_fn300">[fn3]</a> Merial answered on March 7, 2011,
denying Velcera's allegations and asserting counterclaims that
included infringement of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>. Cipla was not a
party to the Delaware action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the contempt proceedings, Cipla sought to vacate the 2008
injunction as void, alleging that the district court had lacked
personal jurisdiction over Cipla when it issued the <i>Default</i>
<i>Order</i> in 2008. Cipla and Velcera argued that even if the
injunction rested on sound jurisdictional footing, their
production and sale of PetArmor Plus did not violate the
court's earlier order. Velcera further maintained that, as a
non-party to the underlying <span CLASS="page_no" data-cite="2012 bl 132909 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[***6]</span> default judgment, it was not
subject to the injunction and, regardless, that it had not
acted in concert <span CLASS="page_no" data-cite="103 uspq 2d 1008" data-cite-type="ReporterOfDecisions" data-cite-pageno="1008" data-primary-citation="103 U.S.P.Q.2d 1001">[**1008]</span> with Cipla to violate the injunction. Finally,
Velcera contended that the contempt proceedings should be
stayed pending a decision on the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>'s validity
in the copending Delaware action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court declined to stay the contempt proceedings
and issued its decision on June 21, 2011. The court concluded
that Cipla had been subject to its jurisdiction when it issued
the 2008 injunction pursuant to Federal Rule of Civil Procedure
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">4</a>(k)(2) instead of the Georgia long-arm statute, that PetArmor
Plus was not more than colorably different from Cipla's
previously enjoined Protektor Plus product, and that Cipla and
Velcera had knowingly acted in concert to violate the court's
order. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *8-14. In
light of the defendants' "contumacious" conduct, the court
issued a permanent injunction precluding Cipla from making,
using, selling, or importing into the United States veterinary
products containing fipronil and methoprene and prohibiting
Velcera from doing the same with any such products developed,
manufactured, or packaged with the assistance or participation
of Cipla.<a HREF="#fn400" name="fnref_fn400">[fn4]</a> <i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">Id</a>.</i> at *16-17.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cipla and Velcera timely appealed from the district court's
judgment of contempt; we have jurisdiction pursuant to
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEIMUG003?jcsearch=28%20U.S.C.%20%201295(a)(1)&amp;summary=yes#jcite">28 U.S.C. &sect; 1295</a>(a)(1).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               DISCUSSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review a district court's exercise of personal jurisdiction
over an accused infringer without deference, applying Federal
Circuit law rather than the law of the regional circuit.
<i>Nuance Commc'ns v. Abbyy Software House</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1EJSGA003?jcsearch=626%20f%203d%201222&amp;summary=yes#jcite">626 F.3d 1222</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1EJSGA003?jcsearch=626%20f%203d%201222&amp;summary=yes#jcite">1230</a> (Fed. Cir. 2010). Findings of fact that bear on
personal jurisdiction are reviewed for clear error.
<i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1EJSGA003?jcsearch=626%20F.3d%201222&amp;summary=yes#jcite">Id</a>.</i> When reviewing a district court's determination as
to contempt of an injunction against infringement, we apply an
abuse of discretion standard, <i>Fujifilm Corp. v. Benun</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1DAV5C003?jcsearch=605%20f%203d%201366&amp;summary=yes#jcite">605 F.3d 1366</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1DAV5C003?jcsearch=605%20f%203d%201366&amp;summary=yes#jcite">1370</a> (Fed. Cir. 2010) (per
<span CLASS="page_no" data-cite="681 f 3d 1293" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1293" data-primary-citation="681 F.3d 1283">[*1293]</span> 
curiam), and the factual findings underlying a contempt
decision are reviewed for clear error, <i>TiVo Inc. v.</i>
<i>EchoStar Corp.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FB716003?jcsearch=646%20f%203d%20869&amp;summary=yes#jcite">646 F.3d 869</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FB716003?jcsearch=646%20f%203d%20869&amp;summary=yes#jcite">883</a> (Fed. Cir. 2011) (en
banc). Whether a non-party to an injunction proceeded "in
active concert" with another party bound by that injunction, as
set forth in Fed.R.Civ.P. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L50003?jcsearch=Fed.%20R.%20Civ.%20P.%2065(d)(2)(C)&amp;summary=yes#jcite">65</a>(d)(2)(C), presents an issue of
fact that we review for clear error. <i>Additive Controls</i>
<i>&amp; Measurement Sys., Inc. v. Flowdata, Inc.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X369U3?jcsearch=154%20f%203d%201345&amp;summary=yes#jcite">154 F.3d 1345</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X369U3?jcsearch=154%20f%203d%201345&amp;summary=yes#jcite">1351</a> (Fed. Cir. 1998) ("<i>Additive Controls II"</i>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Between them, Cipla and Velcera (collectively, "Appellants")
present a panoply of arguments disputing various aspects of the
<i>Contempt Order.</i> We will address each in turn.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    I
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants first challenge the contempt judgment as founded on
an invalid injunction, alleging that the district court lacked
personal jurisdiction over Cipla when it issued the default
judgment in 2008. Appellants therefore argue that the district
court erred in denying Cipla's motion to vacate the 2008
default judgment and injunction pursuant to Fed.R.Civ.P.
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L4K003?jcsearch=Fed.%20R.%20Civ.%20P.%2060(b)(4)&amp;summary=yes#jcite">60</a>(b)(4). In particular, Appellants contend that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>
could not have conferred jurisdiction over Cipla in the Middle
District of Georgia due to Cipla's present assertion of consent
to jurisdiction in the Northern District of Illinois <span CLASS="page_no" data-cite="2012 bl 132909 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[***7]</span> and
Merial's failure to observe effective procedures for service of
process in India. Furthermore, Cipla asserts that the district
court's reliance on <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> was impermissible because
Merial did not plead <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> as a basis for personal
jurisdiction in the 2007 complaint.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Merial responds that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> was applicable when it filed
suit in 2007, that Cipla had denied contacts with Illinois or
any other U.S. jurisdiction at that time, and that Cipla's
belated consent to jurisdiction in Illinois does not defeat
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> because there is no independent basis for
jurisdiction in that forum. Merial argues further that Cipla's
complaints regarding service of process are untimely and
therefore waived on appeal. Finally, Merial argues that it is
irrelevant whether or not its original complaint explicitly
mentioned <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> because there is no requirement to plead
a specific basis for personal jurisdiction and because courts
may rely on that rule even when it has not been cited by the
parties.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the reasons set forth below, we hold that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>
supports the district court's exercise of personal jurisdiction
over Cipla in entering the 2008 default judgment and injunction
<span CLASS="page_no" data-cite="103 uspq 2d 1009" data-cite-type="ReporterOfDecisions" data-cite-pageno="1009" data-primary-citation="103 U.S.P.Q.2d 1001">[**1009]</span> and that the district court therefore correctly denied Cipla's
motion to vacate that judgment on jurisdictional grounds.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    A
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204&amp;summary=yes#jcite">Rule 4</a> is the starting point for any personal jurisdiction
analysis in federal court." <i>Synthes (U.S.A.) v. G.M. Dos</i>
<i>Reis Jr. Ind. Com. De Equip. Medico</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FL911?jcsearch=563%20f%203d%201285&amp;summary=yes#jcite">563 F.3d 1285</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FL911?jcsearch=563%20f%203d%201285&amp;summary=yes#jcite">1293</a>
(Fed. Cir. 2009) (citing Fed.R.Civ.P. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204&amp;summary=yes#jcite">4</a> and <i>Omni Capital</i>
<i>Int'l Ltd. v. Rudolf Wolff &amp; Co.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NU2F?jcsearch=484%20us%2097&amp;summary=yes#jcite">484 U.S. 97</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NU2F?jcsearch=484%20us%2097&amp;summary=yes#jcite">104</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NU2F?jcsearch=108%20supreme%20court%20404&amp;summary=yes#jcite">108 S.Ct. 404</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NU2F?jcsearch=98%20l%20ed%202d%20415&amp;summary=yes#jcite">98 L.Ed.2d 415</a> (1987)). Personal jurisdiction
over foreign defendants in federal court typically depends on
the existence of sufficient contacts between the defendant and
the forum state, requiring the plaintiff to establish that the
exercise of personal jurisdiction over the defendant would
satisfy the forum state's long-arm statute and comport with
constitutional principles of due process such that the
defendant would be subject to personal jurisdiction in the
courts of the forum state. <i>See generally</i> 4A Charles
Alan Wright, et al., <i>Federal Practice and Procedure</i>
&sect; 1069 (3d ed.).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> was adopted to provide a forum for federal claims
in situations
<span CLASS="page_no" data-cite="681 f 3d 1294" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1294" data-primary-citation="681 F.3d 1283">[*1294]</span> 
where a foreign defendant lacks substantial contacts with
any single state but has sufficient contacts with the United
States as a whole to satisfy due process standards and justify
the application of federal law. <i>Synthes</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FL911?jcsearch=563%20f%203d%201285&amp;summary=yes#jcite">563 F.3d at 1295-96</a> (citing advisory committee notes to the 1993 amendment
establishing <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>). <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> thus approximates a
federal long-arm statute, allowing district courts to exercise
personal jurisdiction even if the defendant's contacts with the
forum state would not support jurisdiction under that state's
long-arm statute, as long as (1) the plaintiffs claim arises
under federal law, (2) the defendant is not subject to personal
jurisdiction in the courts of any state, and (3) the exercise
of jurisdiction satisfies due process requirements.
<i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FL911?jcsearch=563%20F.3d%201285&amp;summary=yes#jcite">Id. at 1293-94</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    B
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As noted, one precondition for applying <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> is that
the defendant must not be subject to personal <span CLASS="page_no" data-cite="2012 bl 132909 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[***8]</span> jurisdiction in
the courts of any state (sometimes called the "negation
requirement"). <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FL911?jcsearch=563%20F.3d%201285&amp;summary=yes#jcite">Id. at 1293</a>. Although the burden of
establishing personal jurisdiction ordinarily falls on the
plaintiff, in the context of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> that general
proposition would saddle the plaintiff with an extraordinary
challenge in "proving a negative many times over," that is,
demonstrating that the defendant is <i>not</i> subject to
jurisdiction in each of the fifty states. <i>Touchcom, Inc. v.</i>
<i>Bereskin &amp; Parr</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d 1403</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">1413</a> (Fed. Cir. 2009).
We have therefore adopted a burden-shifting mechanism so that
"if the defendant contends that he cannot be sued in the forum
state and refuses to identify any other where suit is possible,
then the federal court is entitled to use <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>."
<i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20F.3d%201403&amp;summary=yes#jcite">Id. at 1415</a> (quoting <i>ISI Int'l Inc. v. Borden</i>
<i>Ladner Gervais LLP</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d 548</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">551</a> (7th Cir. 2001)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During the contempt proceedings, Cipla identified the Northern
District of Illinois as an alternate forum for suit and claimed
that if it had been sued there "in October 2007 or 2008, Cipla
would have agreed that there was personal jurisdiction."
Appellants contend that this proclamation necessarily divested
the district court of personal jurisdiction and consequently
rendered the default judgment void. In contrast, Merial
maintains, and the district court held, that the proper inquiry
when a defendant seeks to overturn a default judgment
predicated on <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by consenting to an alternate forum
"is to determine whether the defaulted action could have been
brought in that designated forum in the first place under that
forum's long-arm jurisdiction." <i>Contempt Order</i>,
[<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9. Finding that Illinois law would not have
supported personal jurisdiction over Cipla in 2007 based on
Cipla's contacts with Illinois at that time, the district court
held that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>'s negation requirement had been
satisfied notwithstanding Cipla's post-judgment designation of
an alternative forum. <i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Id</a>.</i> We agree with the district
court's analysis and conclusion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court correctly concluded that Cipla's <i>ex</i>
<i>post</i> consent to suit in the Northern District of Illinois
was not independently sufficient to prevent it from exercising
personal jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. Discussing the
negation requirement in <i>Touchcom</i>, we stated that a
defendant can "avoid the application of [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>] only
when it designates a suitable forum in which the plaintiff
<i>could have brought suit.</i>" <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a> (emphasis
added). Contrary to Cipla's contentions, a defendant cannot
defeat <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by simply naming another state; the
defendant's burden under the negation requirement entails
identifying a forum where the plaintiff <i>could have</i>
brought suit &mdash; a forum where jurisdiction would have been
proper at the time of filing, regardless of consent. Consistent
with that obligation, a defendant
<span CLASS="page_no" data-cite="681 f 3d 1295" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1295" data-primary-citation="681 F.3d 1283">[*1295]</span> 
does not identify "a more <i>appropriate</i> state" by
suggesting an alternative forum with no basis for personal
jurisdiction <span CLASS="page_no" data-cite="103 uspq 2d 1010" data-cite-type="ReporterOfDecisions" data-cite-pageno="1010" data-primary-citation="103 U.S.P.Q.2d 1001">[**1010]</span> but for its consent. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20F.3d%201403&amp;summary=yes#jcite">Id. at 1414</a> (quoting
<i>ISI</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 552</a>) (emphasis added). Absent some
independent basis for jurisdiction, neither forum is manifestly
more appropriate than <span CLASS="page_no" data-cite="2012 bl 132909 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[***9]</span> the other in such situations, and we see
little reason to conclude that the defendant's preference
should prevail when choosing among districts of equivalent
jurisdictional competence based on equal contacts &mdash; or
lack thereof &mdash; with the defendant.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917883" href="#headnote_pq2-dec_917883">[1]</a> In any event, we need not decide today the general requirements
for a defendant to prevent the application of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by
consenting to suit in another jurisdiction, for it suffices in
this case to hold that a defendant, like Cipla, challenging a
prior default judgment may not do so by naming another forum
that would not have had an independent basis for jurisdiction
at the time of the original complaint. As the district court
recognized, the incentives for gamesmanship under a contrary
rule would be particularly acute in such cases because the
defaulting party could use a simple, unilateral statement of
consent not only to achieve transfer into a forum it considers
more convenient (or less convenient for its opponent), but also
to undo an adverse final judgment for the chance to litigate
from a clean slate. <i>See Contempt Order</i>,
[<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9 ("Allowing a defendant to avoid the consequences
of a default after the fact simply by professing that it will
now consent to jurisdiction if the default is lifted creates an
opportunity for mischief and manipulation of the courts."). In
sum, the district court applied the correct standard in
evaluating a default judgment premised on <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by
requiring Cipla to identify an alternative forum where Merial
could have brought suit in 2007.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition, we find no clear error in the district court's
application of the foregoing principles to the facts of this
case. To support its claims that personal jurisdiction would
have existed in Illinois, Cipla presented documents indicating
that it had a relationship with an Illinois corporation dating
to 2003, but that evidence contains only bare statements of
expected collaboration and provides no details regarding the
extent of any resulting contacts with Illinois by the time
Merial filed suit. Cipla also submitted evidence suggesting
that it made "over 86 shipments or sales of products" to
companies in Illinois in the past three years. Br.
Def.-Appellant Cipla at 32 (citing J.A. 2684-2808). But that
evidence does not show that any such shipments arrived in
Illinois before Merial filed suit in November 2007, <a HREF="#fn500" name="fnref_fn500">[fn5]</a> nor
does it provide any information on the revenue or sales
generated by the listed shipments. After conducting a careful
analysis of the Illinois long-arm statute, the district court
concluded that the evidence of alleged contacts provided an
insufficient basis to conclude that Cipla would have been
subject to personal jurisdiction in the Northern District of
Illinois for the claims asserted in the 2007 complaint. In view
of the available evidence, that decision was not in error.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    C
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As a predicate to establishing personal jurisdiction,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> also requires service of process or waiver of service,
and Federal Rule of Civil Procedure <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(f)&amp;summary=yes#jcite">4</a>(f) governs the
requirements for serving <span CLASS="page_no" data-cite="2012 bl 132909 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[***10]</span> a party in a foreign country.
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(f)(1)&amp;summary=yes#jcite">Rule 4(f)(1)</a> indicates that a party may be served outside
<span CLASS="page_no" data-cite="681 f 3d 1296" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1296" data-primary-citation="681 F.3d 1283">[*1296]</span> 
of the United States by "internationally agreed means . . .
such as those authorized by the Hague Convention on the Service
Abroad of Judicial and Extrajudicial Documents" ("the Hague
Convention"). India became a signatory to the Hague Convention,
effective August 1, 2007. In so doing, India prohibited service
through channels including mail and private process servers and
instead required foreign plaintiffs to effect service through
the Central Authority of India. <i>See Tuckerbmok Alt. Invs.,</i>
<i>LP v. Banerjee</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1ELEKC003?jcsearch=754%20f%20supp%202d%20177&amp;summary=yes#jcite">754 F.Supp.2d 177</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1ELEKC003?jcsearch=754%20f%20supp%202d%20177&amp;summary=yes#jcite">181-82</a> (D.Mass. 2010).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants argue that exercising personal jurisdiction over
Cipla pursuant to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> would violate due process
because Merial's 2007 service in India was legally deficient.
Appellants allege that when it filed the 2007 complaint, Merial
served Cipla in Mumbai via "courier and registered post" in an
attempt to comply with <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(f)(2)(A)&amp;summary=yes#jcite">Rule 4(f)(2)(A)</a>, but <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(f)(2)&amp;summary=yes#jcite">Rule 4(f)(2)</a>
generally applies only "if there is no internationally agreed
means" of service. Because Merial bypassed the Central
Authority of India, Appellants assert that Merial's service of
process failed to meet mandatory standards under the Hague
Convention and was therefore insufficient to support personal
jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. Accordingly, Appellants argue
that the district court's 2008 default order and injunction
must be vacated as void for lack of personal jurisdiction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917884" href="#headnote_pq2-dec_917884">[2]</a> As Merial correctly notes, however, Appellants have raised the
issue of insufficient <span CLASS="page_no" data-cite="103 uspq 2d 1011" data-cite-type="ReporterOfDecisions" data-cite-pageno="1011" data-primary-citation="103 U.S.P.Q.2d 1001">[**1011]</span> service for the first time on appeal. As
that contention surely could have been, but was not, presented
in Cipla's Rule 60(b)(4) motion or raised before the district
court during the subsequent contempt proceedings, we deem that
argument waived and need not consider it here. <i>See SEC v.</i>
<i>Internet Solutions for Bus. Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1864HO003?jcsearch=509%20f%203d%201161&amp;summary=yes#jcite">509 F.3d 1161</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1864HO003?jcsearch=509%20f%203d%201161&amp;summary=yes#jcite">1167</a> (9th
Cir. 2007).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    D
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917885" href="#headnote_pq2-dec_917885">[3]</a> In general, parties may satisfy federal pleading standards by
alleging personal jurisdiction generally, without asserting a
specific basis for the court's personal jurisdiction over a
defendant. 4 Wright, et al., <i><cite>supra</cite></i>, <cite>&sect; 1067.6</cite>.
Furthermore, our precedent holds that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> can be
considered even when the plaintiff has affirmatively pled a
different basis for personal jurisdiction. <i>See</i>
<i>Touchcom</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1410</a> ("The court did not examine
whether <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> permitted the exercise of personal
jurisdiction [because the plaintiff] did not allege that that
rule permitted the exercise of jurisdiction. However . . . we
are entitled to consider it."); <i>see also ISI</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 551</a> ("Although the parties did not alert the district judge
to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. . . . Federal courts are entitled to apply the
right body of law, whether the parties name it or not.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the 2007 complaint, Merial alleged that the district court
had "personal jurisdiction over CIPLA by virtue of its actions
. . . within this State and judicial district, or its
systematic and continuous contact with this State and judicial
district," J.A. 837, and that allegation stood uncontested
until the contempt proceedings arose several years later. In
the contempt proceedings, Cipla argued, and <span CLASS="page_no" data-cite="2012 bl 132909 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[***11]</span> the district court
concluded, that the available record did "not support a finding
that Cipla had sufficient contacts with the state of Georgia
for it to be subject to personal jurisdiction under the Georgia
long-arm statute for the present action," but the court agreed
with Merial that it could evaluate whether its jurisdictional
requirements had nonetheless been satisfied pursuant to
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *8 n. 9
(citing <i>Touchcom</i>,
<span CLASS="page_no" data-cite="681 f 3d 1297" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1297" data-primary-citation="681 F.3d 1283">[*1297]</span> 
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a>). Cipla argues that it was entitled to
rely on the allegations evident from the face of Merial's
complaint. Since the 2007 complaint recited a defective basis
for jurisdiction, Cipla argues that it rightly declined to
answer in the interest of forgoing futile litigation and that
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> should be unavailable until the default judgment
is vacated and Merial's complaint is formally amended to
provide Cipla with a full opportunity to respond on the merits.
As explained below, we find those arguments unpersuasive.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As Cipla notes, "[a] defendant is always free to ignore the
judicial proceedings, risk a default judgment, and then
challenge that judgment on jurisdictional grounds." <i>Ins.</i>
<i>Corp. of Ir., Ltd. v. Compagnie des Bauxites de Guinee</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. 694</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">706</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. 2099</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d 492</a> (1982). Upon
receiving a complaint, defendants are of course entitled to
evaluate the circumstances and forge their own strategic
decisions; the soundness of those decisions, however, is
another matter. <i>See</i> Restatement (Second) of Judgments,
&sect; 65 cmt. b. ("When the person knew about the action but
perceived that the court lacked . . . jurisdiction, he is given
a right to ignore the proceeding <i>at his own risk</i> but
to suffer no detriment <i>if his assessment proves</i>
<i>correct</i>") (emphases added). Cipla essentially urges that,
because the 2007 complaint did not refer to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>, the
possibility of jurisdiction arising under that rule did not
factor into its decision not to appear, and the district
court's subsequent invocation of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> as its basis for
asserting personal jurisdiction constituted an unfair change in
circumstances and therefore compels a return to square one in
this litigation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  But such claims of reliance and unfair surprise ring hollow
where, as here, it is beyond dispute that Cipla had actual
notice of suit and chose to risk a default judgment, based on
its subjective assessment of the complaint<a HREF="#fn600" name="fnref_fn600">[fn6]</a> and despite
existing precedent indicating that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> could apply
whether or not it was raised by the parties. <i>See ISI</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 551</a>. Regardless of the specific jurisdictional
allegations in the 2007 complaint, Cipla should have
apprehended that a Rule 4(k)(2) inquiry might arise,
particularly as a foreign company believing itself to be
outside the reach of the forum state's long-arm statute.
Furthermore, even though Cipla's initial belief that the
complaint recited an incorrect basis for jurisdiction was
ultimately vindicated, that issue remained an open question at
the time, and Cipla had the option of filing a pre-answer
motion under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L16003?jcsearch=Fed.%20R.%20Civ.%20P.%2012(b)(2)&amp;summary=yes#jcite">Rule 12(b)(2)</a> to settle all issues of personal
jurisdiction up front. Cipla instead chose to do nothing, and
it must bear the consequences <span CLASS="page_no" data-cite="2012 bl 132909 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[***12]</span> of that decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Cipla attempts to distinguish <i>Touchcom</i> on the basis
that we were not reviewing a default <span CLASS="page_no" data-cite="103 uspq 2d 1012" data-cite-type="ReporterOfDecisions" data-cite-pageno="1012" data-primary-citation="103 U.S.P.Q.2d 1001">[**1012]</span> judgment in that case, so
vacatur was not necessary there for the plaintiff to amend its
complaint on remand. Those distinctions are unavailing. In
<i>Touchcom</i>, the plaintiffs pursued a legal malpractice
claim against a Canadian law firm for alleged errors in
prosecuting a U.S. patent, alleging that the governing state
long-arm statute conferred personal jurisdiction on the
district court in view of the defendant's contacts with the
forum state. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1409-10</a>. The district court dismissed
for lack of personal jurisdiction because the plaintiffs had
not pled sufficient facts to establish personal jurisdiction
under state law. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20F.3d%201403&amp;summary=yes#jcite">Id. at 1409</a>. Although we agreed
<span CLASS="page_no" data-cite="681 f 3d 1298" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1298" data-primary-citation="681 F.3d 1283">[*1298]</span> 
with the district court's analysis under state law, we
nonetheless reversed and remanded on the basis that the
district court could exert personal jurisdiction over the
defendants pursuant to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20F.3d%201403&amp;summary=yes#jcite">Id. at 1411-12</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=1418&amp;summary=yes#jcite">1418</a>. Citing <i>ISI</i>, we held that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> applied
even though it had never been raised at any point prior to
appeal, much less recited as a basis for jurisdiction in the
plaintiffs' original complaint. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20F.3d%201403&amp;summary=yes#jcite">Id. at 1410-11</a>.
Nowhere was our remand decision conditioned on subsequent
formal amendments to the complaint &mdash; indeed, the issue
was not even mentioned &mdash; and we do not read
<i>Touchcom</i> as being so limited. Contrary to Cipla's
contentions, the main distinction we see between the facts in
<i>Touchcom</i> and the present dispute is that here Merial
did raise <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> before the district court such that the
parties were able to contest its application prior to appeal,
which, if anything, favors Merial's position. We therefore see
no reason to distinguish <i>Touchcom</i> based on the facts
of this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Eleventh Circuit considered the retroactive application of
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> following a default judgment in <i>Oldfield v.</i>
<i>Pueblo de Bahia Lora, S.A.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20f%203d%201210&amp;summary=yes#jcite">558 F.3d 1210</a> (11th Cir. 2009).
In that case, a U.S. plaintiff brought suit against a foreign
corporation to recover for injuries he suffered at a resort
operated by the defendant in Costa Rica. The plaintiffs
complaint alleged personal jurisdiction under the relevant
state long-arm statute, and when the defendant did not appear,
the district court entered a default judgment. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20F.3d%201210&amp;summary=yes#jcite">Id.
at 1215</a>. The defendant later moved to set aside the default
judgment for want of personal jurisdiction, and the plaintiff
countered by raising <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> for the first time as an
alternative basis for jurisdiction. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20F.3d%201210&amp;summary=yes#jcite">Id. at 1216</a>. Under
circumstances thus very similar to the appeal before us, and
without requiring amendment of the complaint, the Eleventh
Circuit court performed a full <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> analysis. As Cipla
points out, the court in <i>Oldfield</i> ultimately concluded
that Rule 4(k)(2) did not support jurisdiction over the
defendant. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20F.3d%201210&amp;summary=yes#jcite">Id. at 1223-24</a>; <i>see</i> Br.
Def.-Appellant Cipla at 24-25. But that was because the
substantive requirements of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> had not been met, not
because <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> had been omitted from the complaint.
<i>See Oldfield</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20f%203d%201210&amp;summary=yes#jcite">558 F.3d at 1223-24</a>. As far as the
propriety of considering <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> for the first time <span CLASS="page_no" data-cite="2012 bl 132909 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[***13]</span> after
a default judgment, <i>Oldfield</i> thus supports the
district court's approach in this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, we note that Cipla had a full opportunity to litigate
over personal jurisdiction during the contempt proceedings,
and, having lost on that issue, now insists that the default
judgment must nonetheless be vacated because the basis for
jurisdiction alleged in the 2007 complaint differed from the
basis ultimately relied upon by the district court. But the
judgment's legal viability is not keyed to the particular
grounds for personal jurisdiction set out in the complaint. The
important question is whether the district court ultimately had
actual jurisdiction over the parties. Once it received notice
of suit in 2007, the choice was Cipla's whether the
jurisdictional question should be settled then or at some point
postjudgment. With the benefit of hindsight, Cipla would
understandably prefer to turn back the litigation clock to
reconsider that choice, but the district court's default
judgment was premised on a valid exercise of personal
jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>, and we therefore decline to
upset its decision on that basis.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   II
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants next dispute the district court's decision to deny
its request for a stay of the contempt proceedings pending
resolution of the parallel Delaware action. The district court
held that the "first-to-file" rule would not support a stay
and,
<span CLASS="page_no" data-cite="681 f 3d 1299" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1299" data-primary-citation="681 F.3d 1283">[*1299]</span> 
moreover, that the Delaware action was not in fact the
first filed. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *1
n. 3. Appellants contend that the district court should have
issued a stay because the Delaware action was filed before
Merial instituted the contempt proceedings and because the
Delaware action raised pivotal questions of validity and
infringement that warranted a full trial and could have
rendered the contempt proceedings moot. Appellants thus ask
that we vacate the district court's judgment and remand with
instructions to stay further contempt proceedings pending a
final determination on infringement <span CLASS="page_no" data-cite="103 uspq 2d 1013" data-cite-type="ReporterOfDecisions" data-cite-pageno="1013" data-primary-citation="103 U.S.P.Q.2d 1001">[**1013]</span> and validity of the
&prime;329 patent in the Delaware action. This we decline to
do.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The "first-to-file" rule is a doctrine of federal comity,
intended to avoid conflicting decisions and promote judicial
efficiency, that generally favors pursuing only the first-filed
action when multiple lawsuits involving the same claims are
filed in different jurisdictions. <i>See generally Genentech,</i>
<i>Inc. v. Eli Lilly &amp; Co.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X358V7?jcsearch=998%20f%202d%20931&amp;summary=yes#jcite">998 F.2d 931</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X358V7?jcsearch=998%20f%202d%20931&amp;summary=yes#jcite">937-38</a>
(Fed. Cir. 1993); <i>Church of Scientology of Cal. v. U.S. Dep't</i>
<i>of the Army</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XABDKS?jcsearch=611%20f%202d%20738&amp;summary=yes#jcite">611 F.2d 738</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XABDKS?jcsearch=611%20f%202d%20738&amp;summary=yes#jcite">749-50</a> (9th Cir. 1979). The
filing date of an action derives from the filing of the
complaint. Fed.R.Civ.P. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0E003?jcsearch=Fed.%20R.%20Civ.%20P.%203&amp;summary=yes#jcite">3</a>; <i>Pacesetter Sys., Inc. v.</i>
<i>Medtronic, Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3PBQA?jcsearch=678%20f%202d%2093&amp;summary=yes#jcite">678 F.2d 93</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3PBQA?jcsearch=678%20f%202d%2093&amp;summary=yes#jcite">96</a> n. 3 (9th Cir. 1982).
Under the first-to-file rule, a district court may choose to
stay, transfer, or dismiss a duplicative later-filed action,
although there are exceptions and the rule is not rigidly or
mechanically applied &mdash; "an ample degree of discretion,
appropriate for disciplined and experienced judges, must be
left to the lower courts." <i>Kerotest Mfg. Co. v. C-OTwo Fire</i>
<i>Equip. Co.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C26K?jcsearch=342%20us%20180&amp;summary=yes#jcite">342 U.S. 180</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C26K?jcsearch=342%20us%20180&amp;summary=yes#jcite">183-84</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C26K?jcsearch=72%20supreme%20court%20219&amp;summary=yes#jcite">72 S.Ct. 219</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C26K?jcsearch=96%20l%20ed%20200&amp;summary=yes#jcite">96 L.Ed. 200</a> (1952).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917886" href="#headnote_pq2-dec_917886">[4]</a> As an initial matter, we disagree with Appellants' contention
that the Delaware <span CLASS="page_no" data-cite="2012 bl 132909 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[***14]</span> action antedates the matter now before us on
appeal. Velcera filed its declaratory judgment complaint in
Delaware on February 11, 2011, approximately six weeks before
Merial moved on March 28, 2011, to hold Cipla in contempt. But
the date of Merial's contempt <i>motion</i> is irrelevant in
determining which <i>action</i> was filed first &mdash; what
matters is the initiation of suit. Here, the contempt
proceedings elaborated a preexisting case that originated with
Merial's initial infringement complaint against Cipla, filed in
November 2007. The district court thus correctly viewed the
contempt proceedings as first filed. Furthermore, even if the
Delaware action could be considered the first suit filed, the
district court was well within its considerable discretion in
concluding that principles of comity would not support a stay
because the precise issues at stake differed between the
proceedings, and a key party (Cipla) was absent from the
Delaware action. <i>See Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753,
at *1 n. 3. We therefore affirm the denial of Velcera's motion
for stay.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   III
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants next urge reversal on grounds that the district
court's analysis of PetArmor Plus failed to apply the correct
standard for determining contempt based on a newly accused
product. On review, and as described more fully below, we
uphold the district court's judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have recently applied a modified analysis to contempt
determinations in the context of alleged continuing
infringement in violation of an injunction. Under
<i>TiVo</i>, contempt requires proof that (1) the newly
accused product is no more than colorably different from the
previously adjudged infringing product, and (2) the newly
accused product actually infringes the asserted patent.
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FB716003?jcsearch=646%20f%203d%20869&amp;summary=yes#jcite">646 F.3d at 882</a>. The district court found that Merial satisfied
both requirements as to PetArmor Plus in the contempt
proceedings. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at
*11-12.
<span CLASS="page_no" data-cite="681 f 3d 1300" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1300" data-primary-citation="681 F.3d 1283">[*1300]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917887" href="#headnote_pq2-dec_917887">[5]</a> Appellants attack both findings as founded on inadequate
evidence and reliant on unsustainable assumptions derived from
the 2008 default judgment against Cipla. At the outset, Velcera
complains that &mdash; as a non-party to the original default
proceedings &mdash; it never received a full and fair
opportunity to litigate various issues including whether the
&prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a> is valid, whether Cipla's Protektor
Plus.product infringed the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>, or whether
Protektor Plus ever even existed. Those arguments are baseless.
Velcera, as an unsolicited intervener in this action, joined
subject to all prior determinations of fact and law that
preceded its intervention. <i>Knowles v. Bd. of Pub.</i>
<i>Instruction of Leon (My.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X429K1?jcsearch=405%20f%202d%201206&amp;summary=yes#jcite">405 F.2d 1206</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X429K1?jcsearch=405%20f%202d%201206&amp;summary=yes#jcite">1207</a> (5th
Cir. 1969). Patent validity and infringement by an originally
accused product are generally not open to challenge in contempt
proceedings, <i>Additive Controls II</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X369U3?jcsearch=154%20f%203d%201345&amp;summary=yes#jcite">154 F.3d at 1350</a>,
and for purposes of this litigation, the 2008 default judgment
against Cipla established, among other things, that the
&prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a> was not invalid and was in-fringed by Cipla's
Protektor Plus product. In short, the time for contesting those
underlying determinations has passed, and we will not consider
them anew in this appeal.
<span CLASS="page_no" data-cite="2012 bl 132909 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[***15]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants next argue that the district court could not
competently evaluate whether colorable differences exist
between PetArmor Plus and Protektor Plus because the default
judgment allegedly offered no guidance on which specific
features of Protektor Plus were focused on to establish
infringement. In support of its position, Appellants rely on
our statement in <i>TiVo</i> that "one should focus on those
elements of the adjudged infringing products that the patentee
previously contended, and proved, satisfy specific limitations
of the asserted claims." <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FB716003?jcsearch=646%20f%203d%20869&amp;summary=yes#jcite">646 F.3d at 882</a>. Again insisting that
Merial never "proved" infringement <span CLASS="page_no" data-cite="103 uspq 2d 1014" data-cite-type="ReporterOfDecisions" data-cite-pageno="1014" data-primary-citation="103 U.S.P.Q.2d 1001">[**1014]</span> by Protektor Plus,
Appellants argue that the colorable differences analysis did
not rest on affirmatively adjudged infringing features.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917888" href="#headnote_pq2-dec_917888">[6]</a> We conclude that the district court applied the correct
standards and committed no clear error in finding no more than
colorable differences between PetArmor Plus and Protektor Plus.
In contempt proceedings following a contested infringement
action, as in <i>TiVo</i>, it will often be that the
underlying infringement litigation focused detailed attention
on a few heavily disputed claim limitations and certain
corresponding elements of an infringing product, and the
colorable differences analysis in such cases will benefit from
that precision. But when, as here, infringement has been
established through default, the judgment is no less binding or
authoritative simply because comprehensive and painstaking
factual analyses regarding every claim limitation may have been
unnecessary or impractical at the time of the initial decision.
As such, whether or not the default order here included an
exhaustive infringement analysis, it necessarily and
conclusively established that Protektor Plus met each
limitation recited in the asserted claims of the &prime;329
patent. For example, claim 1 of the &prime;329 patent requires
a spot-on pest control composition comprising (1) a synergistic
effective amount of fipronil, (2) a synergistic effective
amount of an IGR, and (3) at least one customary spot-on
formulation adjuvant. &prime;329 patent col.10 11.11-15. The
evidence showed that Protektor Plus contained 9.7% fipronil,
11.8% methoprene, and at least one customary spot-on adjuvant
&mdash; all of which Cipla admitted by default in 2008.
<i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *6. By comparison,
the district court found during the contempt proceedings that
PetArmor Plus for cats contains 9.8% fipronil, 11.8%
methoprene, and at least one customary spot-on adjuvant.
<i><cite>Id</cite>.</i> at *12. Furthermore,
<span CLASS="page_no" data-cite="681 f 3d 1301" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1301" data-primary-citation="681 F.3d 1283">[*1301]</span> 
the court credited Merial's expert testimony that any two
spot-on adjuvants would function interchangeably and that
replacing one for another in any such pest control composition
would not amount to a colorable difference. <i><cite>Id</cite>.</i> The
district court thus had ample basis to conclude that PetArmor
Plus and Protektor Plus are not more than colorably different.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants also fault the district court's conclusion that
PetArmor Plus infringes the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>. Appellants argue
that the district court relied on inadequate evidence <span CLASS="page_no" data-cite="2012 bl 132909 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[***16]</span> and
erroneously compared PetArmor Plus to Merial's Frontline Plus
rather than the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a> claims themselves.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917889" href="#headnote_pq2-dec_917889">[7]</a> It is undisputed that Merial's Frontline Plus product is
covered by the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>'s claims, and, contrary to the
Appellants' contentions, "[o]ur case law does not contain a
blanket prohibition against comparing the accused product to a
commercial embodiment" in an infringement analysis. <i>Adams</i>
<i>Respiratory Therapeutics, Inc. v. Perrigo Co.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1DTP52003?jcsearch=616%20f%203d%201283&amp;summary=yes#jcite">616 F.3d 1283</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1DTP52003?jcsearch=616%20f%203d%201283&amp;summary=yes#jcite">1288</a> (Fed. Cir. 2010). The district court thus elected to
compare the accused product to Frontline Plus, and we see no
error in that decision, particularly given its context in a
summary contempt proceeding where such an approach would be
especially convenient or expeditious and the benchmark
commercial product represents a recognized embodiment of the
patent at issue. On the merits, the district court considered
undisputed evidence that PetArmor Plus contains precisely the
same concentrations of fipronil and methoprene as Frontline
Plus, and that those concentrations constitute synergistically
effective amounts as recited in the claims. Indeed, Velcera not
only represented to the EPA that PetArmor Plus is essentially
identical to Frontline Plus, but also explicitly traded on the
products' equivalence. <i>See, e.g.</i>, J.A. 6745, 6753-54
(PetArmor Plus packaging prominently stating "COMPARE TO
FRONTLINE PLUS &mdash; same active ingredients," and PetArmor
Plus promotional materials emphasizing identity between the
PetArmor Plus and Frontline Plus formulations). Further, Merial
highlighted trial testimony in which Dennis Steadman, Velcera's
CEO, "readily admitted at the hearing that if the &prime;329
Patent is valid, then PetArmor Plus violates that Patent."
<i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *12. That
testimony was as follows:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  THE COURT: Mr. Steadman, let me just make sure I
  understand one thing you testified to. I understand
  that you made the conscious decision that PetArmor
  Plus you did not feel violated the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>
  because you believed the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/1?citation=usp%206096329&amp;summary=yes#jcite">329 patent</a> was
  invalid. Correct?
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  THE WITNESS: That's correct.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  THE COURT: If &mdash; and I know you don't agree with
  this. But if the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/1?citation=usp%206096329&amp;summary=yes#jcite">329 patent</a> were valid, then
  you would acknowledge that PetArmor Plus would
  infringe on that patent, if it were valid. THE
  WITNESS: If it were valid, that combination, I &mdash;
  yeah, I believe would.
<span CLASS="page_no" data-cite="103 uspq 2d 1015" data-cite-type="ReporterOfDecisions" data-cite-pageno="1015" data-primary-citation="103 U.S.P.Q.2d 1001">[**1015]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  . . . .
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  THE COURT: You're betting the store on the invalidity
  of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>. THE WITNESS: You betcha.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
J.A. 4903-06. One would be hard-pressed to conceive of more
compelling testimonial evidence on infringement, particularly
when those statements come from the defendant's chief executive
regarding his own product. In assessing whether PetArmor Plus
infringes the &prime;329 patent, the district court thus had
before it considerable evidence indicating infringement, and we
discern no error in its affirmative conclusion on the basis of
that evidence. In view of the foregoing, the district court
appropriately considered both prongs of the contempt analysis
as required under <i>TiVo</i>, and its conclusions were not
clearly erroneous.
<span CLASS="page_no" data-cite="681 f 3d 1302" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1302" data-primary-citation="681 F.3d 1283">[*1302]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   IV
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Appellants' next argument raises territoriality <span CLASS="page_no" data-cite="2012 bl 132909 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[***17]</span> concerns
with the district court's contempt judgment, emphasizing that
Cipla restricted its involvement in the PetArmor Plus venture
to activities in India. After analyzing Cipla's role in the
development, manufacture, and distribution of PetArmor Plus,
the district court nonetheless concluded that Cipla had
contemptuously "caused an infringing product to be sold in the
United States, in direct violation of the Court's March 6, 2008
order." <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *13.
According to Appellants, the district court thereby
overextended U.S. law to penalize Cipla for conduct that
occurred entirely overseas. We find no such extra-territorial
infirmity in the judgment, as described more fully below.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants first advance the blanket proposition that domestic
patent law does not, and was not intended to, reach past the
territorial limits of the United States. According to
Appellants, "decades of precedent" hold that extraterritorial
conduct cannot constitute patent infringement under
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20usc%20271&amp;summary=yes#jcite">35 U.S.C. &sect; 271</a>. Br. Def.-Appellant Velcera at 26-27 (citing
<i>Deepsouth Packing Co. v. Laitmm Corp.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C87I?jcsearch=406%20us%20518&amp;summary=yes#jcite">406 U.S. 518</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C87I?jcsearch=92%20supreme%20court%201700&amp;summary=yes#jcite">92 S.Ct. 1700</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C87I?jcsearch=32%20l%20ed%202d%20273&amp;summary=yes#jcite">32 L.Ed.2d 273</a> (1972); <i>Brown v.</i>
<i>Duchesne</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XLVR7R?jcsearch=60%20us%20183&amp;summary=yes#jcite">60 U.S. 183</a>, 19 How. 183, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XLVR7R?jcsearch=15%20l%20ed%20595&amp;summary=yes#jcite">15 L.Ed. 595</a> (1856);
<i>Rotec Indus., Inc. v. Mitsubishi Corp.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FEOP?jcsearch=215%20f%203d%201246&amp;summary=yes#jcite">215 F.3d 1246</a>
(Fed. Cir. 2000)); Br. Def.-Appellant Cipla at 45-48 (same).
Merial responds that foreign acts can violate U.S. patent law
if, like Cipla's, they induce acts of direct infringement
within the United States.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917890" href="#headnote_pq2-dec_917890">[8]</a> Although we recognize the fundamental territoriality of U.S.
patent law, <i>see Microsoft Corp. v. AT &amp; T Corp.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XRIK83QNB5G0?jcsearch=550%20us%20437&amp;summary=yes#jcite">550 U.S. 437</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XRIK83QNB5G0?jcsearch=127%20supreme%20court%201746&amp;summary=yes#jcite">127 S.Ct. 1746</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XRIK83QNB5G0?jcsearch=167%20l%20ed%202d%20737&amp;summary=yes#jcite">167 L.Ed.2d 737</a> (2007), Cipla's
alleged foreign conduct is not necessarily outside the scope of
&sect; 271. To be sure, purely extraterritorial conduct cannot
constitute <i>direct</i> infringement of a U.S. patent, as
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">&sect; 271(a)</a> includes express language limiting its scope to
domestic acts: "[W]hoever without authority makes, uses, offers
to sell, or sells any patented invention, <i>within the United</i>
<i>States</i>, or imports <i>into the United States</i> any
patented invention during the term of the patent therefore,
infringes the patent." <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">35 U.S.C. &sect; 271</a>(a) (2006) (emphases
added). Consistent with this principle, all of the decisions
cited by Appellants concerned claims for direct infringement
and therefore required an infringing act within the United
States. <i>See Deepsouth</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C87I?jcsearch=406%20us%20518&amp;summary=yes#jcite">406 U.S. at 527</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5C87I?jcsearch=92%20supreme%20court%201700&amp;summary=yes#jcite">92 S.Ct. 1700</a>
("to secure the injunction it seeks, Laitram must show a
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">&sect; 271(a)</a> direct infringement by Deepsouth in the United States");
<i>Brown</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XLVR7R?jcsearch=60%20us%20183&amp;summary=yes#jcite">60 U.S. at 193</a> ("The declaration . . . alleges
that the defendant used [the invention] without his consent.");
<i>Rotec</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3FEOP?jcsearch=215%20f%203d%201246&amp;summary=yes#jcite">215 F.3d at 1251</a> ("According to Rotec,
Defendants violated <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">&sect; 271(a)</a> when they `offered to sell'
the invention. . . ."). While those decisions thus support the
proposition that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">&sect; 271(a)</a> direct infringement claims
require domestic infringing acts, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271&amp;summary=yes#jcite">&sect; 271</a>(a) is not the only
provision of &sect; 271. In particular, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">&sect; 271(b)</a>, which
defines infringement by inducement, contains no such
territorial proscription. <i>See</i> <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">35 U.S.C. &sect; 271</a>(b)
("Whoever actively induces infringement of a patent shall be
liable as an infringer."). <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">Section 271(b)</a> therefore does not,
on its face, foreclose liability for extraterritorial acts that
actively induce an act of direct infringement that occurs
within the United States, and Appellants cite no authority to
that effect. We therefore <span CLASS="page_no" data-cite="2012 bl 132909 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[***18]</span> decline to read the statute as being
so limited.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, where a foreign party, with the requisite knowledge
and intent, employs extraterritorial means to actively induce
acts of direct infringement that occur within the United
States, such conduct is not categorically exempt from redress
<span CLASS="page_no" data-cite="681 f 3d 1303" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1303" data-primary-citation="681 F.3d 1283">[*1303]</span> 
under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">&sect; 271(b)</a>. <i>Cf. DSU Med. Corp. v. JMS Co.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X163BBQ003?jcsearch=471%20f%203d%201293&amp;summary=yes#jcite">471 F.3d 1293</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X163BBQ003?jcsearch=471%20f%203d%201293&amp;summary=yes#jcite">1305-06</a> (Fed. Cir. 2006) (en banc in relevant
part) (approving of a jury instruction that read, in part:
"Unlike direct infringement, which must take place in the
United States, induced infringement does not require any
activity by the indirect infringer in this country, so long as
the direct infringement occurs here."). We therefore reject the
Appellants' overbroad contention that acts outside <span CLASS="page_no" data-cite="103 uspq 2d 1016" data-cite-type="ReporterOfDecisions" data-cite-pageno="1016" data-primary-citation="103 U.S.P.Q.2d 1001">[**1016]</span> of the
United States cannot violate any provision of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271&amp;summary=yes#jcite">&sect; 271</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917891" href="#headnote_pq2-dec_917891">[9]</a> Appellants next argue that, even if foreign activities can give
rise to liability in some circumstances, our decision in
<i>International Rectifier Corp. v. Samsung Electronics</i>
<i>Co.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X6CU46?jcsearch=361%20f%203d%201355&amp;summary=yes#jcite">361 F.3d 1355</a> (Fed. Cir. 2004), prohibits a contempt
finding in this case. More specifically, Appellants argue that
their layered contractual arrangements and elaborate
distribution chain &mdash; by which they sought to insulate
themselves from one another through foreign, allegedly
independent intermediaries &mdash; mirror those that on their
facts precluded a contempt judgment in <i>International</i>
<i>Rectifier.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Appellants' reliance on <i>International Rectifier</i> is
misplaced. In <i>International Rectifier</i>, the district
court had enjoined a foreign manufacturer from "making, using,
offering for sale or selling in or importing into the United
States" a patented computer component. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X6CU46?jcsearch=361%20f%203d%201355&amp;summary=yes#jcite">361 F.3d at 1360</a>. The
enjoined foreign manufacturer then contracted with a German
company to make, sell, and deliver unfinished versions of the
patented component outside of the United States, after which
the German company finished and packaged the patented
components for sale to its customers around the world,
including in the United States. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X6CU46?jcsearch=361%20F.3d%20at%201360&amp;summary=yes#jcite">Id. at 1358</a>. Although
the district court held the manufacturer in contempt for
violating the injunction, we reversed, holding that the
manufacturer's extraterritorial conduct had not violated the
injunction and that there was no basis for attributing the
German company's independent actions to the manufacturer.
<i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X6CU46?jcsearch=361%20F.3d%20at%201360&amp;summary=yes#jcite">Id. at 1360-62</a>. But our decision in <i>International</i>
<i>Rectifier</i> turned on the specific terms of the injunction
there at issue, which "track[ed] section <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(a)&amp;summary=yes#jcite">271(a)</a> of the Patent
Act" and therefore prohibited only direct infringement and
could not reach extraterritorial activities. <i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X6CU46?jcsearch=361%20F.3d%20at%201360&amp;summary=yes#jcite">Id.
at 1360</a>. In contrast, Cipla's current overseas activities are not
necessarily outside of the broader injunction now before us,
which prohibits not only direct infringement, but also "any act
that . . . <i>causes or induces</i> infringement" of the
&prime;329 patent. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at
*12. And, unlike in <i>International Rectifier</i>, it is
therefore unnecessary to establish whether Cipla exerted
control over the allegedly independent actions of Omnipharm
and/or QEDetal, for Cipla's own extraterritorial conduct can
violate the present injunction <span CLASS="page_no" data-cite="2012 bl 132909 p 19" data-cite-type="Bloomberg" data-cite-pageno="19" data-primary-citation="">[***19]</span> as indirectly infringing
pursuant to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">&sect; 271(b)</a>. <i>International Rectifier</i>
therefore does not preclude a finding of contempt in this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Cipla contends that the district court's contempt
order lacks any findings on or meaningful discussion of
indirect infringement and argues that the district court
applied an inadequate inducement analysis. According to Cipla,
the district court's conclusion that Cipla "caused" Velcera's
infringement cannot be sustained as a basis for contempt
because it falls short of sufficient factual findings and
misstates the correct legal standard on inducement. We
disagree.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917892" href="#headnote_pq2-dec_917892">[10]</a> Regardless of the precise language used to frame the issue, the
substance of the district court's analysis is clear &mdash;
Cipla violated the injunction because, at a minimum, its
involvement in the PetArmor Plus venture induced infringement
of the &prime;329 patent. To support a finding of inducement
under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XEJ04O003?jcsearch=35%20U.S.C.%20%20271(b)&amp;summary=yes#jcite">&sect; 271(b)</a>,
<span CLASS="page_no" data-cite="681 f 3d 1304" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1304" data-primary-citation="681 F.3d 1283">[*1304]</span> 
the accused infringer must have knowingly and intentionally
induced another party's direct infringement. <i>Global-Tech</i>
<i>Appliances, Inc. v. SEB, S.A.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FGVDU003?jcsearch=98%20U.S.P.Q.2d%201665&amp;summary=yes#jcite">563 U.S. ___</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FGVDU003?jcsearch=131%20supreme%20court%202060&amp;summary=yes#jcite">131 S.Ct. 2060</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FGVDU003?jcsearch=131%20supreme%20court%202060&amp;summary=yes#jcite">2068</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FGVDU003?jcsearch=179%20l%20ed%202d%201167&amp;summary=yes#jcite">179 L.Ed.2d 1167</a> (2011); <i>DSU</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X163BBQ003?jcsearch=471%20f%203d%201293&amp;summary=yes#jcite">471 F.3d at 1306</a>. Here, the district court explicitly found that (1)
PetArmor Plus infringes the &prime;329 patent; (2) Velcera sold
PetArmor Plus in the United States; (3) Cipla and Velcera were
aware of the &prime;329 patent and the 2008 injunction; (4)
Cipla played fundamental roles in manufacturing, packaging, and
assisting in the development of the PetArmor Plus product for
Velcera to sell in the United States; (5) Cipla knew that
PetArmor Plus was to be sold in the United States; and (6)
Cipla knew and intended that such sales would infringe the
&prime;329 patent. Those findings bear directly on the question
of inducement, and they are not clearly erroneous.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nor can we say that those findings are inadequate to support a
finding of inducement or that the district court erred in its
ultimate conclusion that Cipla "caused an infringing product to
be sold in the United States" in direct violation of the
injunction. <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *13.
Although Cipla complains that the district court's use of the
term "caused" signals the application of an incorrect standard
for inducement, the contempt order simply reflects the language
of the injunction itself, which is central to the contempt
analysis and uses the terms "cause" and "induce"
interchangeably to describe prohibited indirectly infringing
conduct.<a HREF="#fn700" name="fnref_fn700">[fn7]</a> Accordingly, <span CLASS="page_no" data-cite="103 uspq 2d 1017" data-cite-type="ReporterOfDecisions" data-cite-pageno="1017" data-primary-citation="103 U.S.P.Q.2d 1001">[**1017]</span> we understand the district court's
conclusion that "Cipla caused an infringing product to be sold
in the United States, in direct violation of the Court's March
6, 2008 Order," <i>id.</i>, to mean that Cipla violated the
injunction's prohibition against any act that induces
infringement of the &prime;<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3014C3128J?jcsearch=usp%206096329&amp;summary=yes#jcite">329 patent</a>. We affirm it as such.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                    V
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Velcera next contends that even if Cipla's conduct violated the
2008 injunction, the district court committed independent error
by also finding Velcera &mdash; a non-party to the 2008 default
judgment &mdash; in contempt for working in "active concert or
participation" with Cipla to violate the 2008 injunction. We
disagree.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917893" href="#headnote_pq2-dec_917893">[11]</a> It is well recognized that courts may not enter injunctions
against <span CLASS="page_no" data-cite="2012 bl 132909 p 20" data-cite-type="Bloomberg" data-cite-pageno="20" data-primary-citation="">[***20]</span> persons or entities that were not party to the
litigation before them. A soundly issued injunction can,
however, affect such non-parties in at least two important
respects &mdash; those who are legally identified with an
enjoined party may be bound as if they themselves were named in
the injunction, and those who act in concert with an enjoined
party to assist in violating the injunction may also be held in
contempt. Fed.R.Civ.P. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L50003?jcsearch=Fed.%20R.%20Civ.%20P.%2065(d)&amp;summary=yes#jcite">65</a>(d); <i>Additive Controls</i>
<i>&amp; Measurement Sys., Inc. v. Flowdata, Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X353KP?jcsearch=96%20f%203d%201390&amp;summary=yes#jcite">96 F.3d 1390</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X353KP?jcsearch=96%20f%203d%201390&amp;summary=yes#jcite">1394-95</a> (Fed. Cir. 1996) ("<i>Additive Controls I</i>"). For
the latter "active concert" form of liability, a non-party to
an injunction may not be held in contempt for its wholly
independent conduct; the law limits contempt liability to
non-parties that "act with an enjoined party to bring about a
result forbidden by the injunction . . . if they are aware of
the injunction and know
<span CLASS="page_no" data-cite="681 f 3d 1305" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1305" data-primary-citation="681 F.3d 1283">[*1305]</span> 
that their acts violate the injunction." <i>Additive</i>
<i>Controls II</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X369U3?jcsearch=154%20f%203d%201345&amp;summary=yes#jcite">154 F.3d at 1353</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Velcera posits that the district court erred by failing to
separately analyze its individual actions under the aiding and
abetting standard, calling repeated attention to what it calls
the "bona fide legal and business relationships" that separated
Velcera from Cipla in the development, production, and sale of
PetArmor Plus. Under a proper analysis, according to Velcera,
its "arms-length" business relationship and lack of a direct
contractual relationship with Cipla evince independent activity
undertaken for purposes other than assisting Cipla in efforts
to violate the injunction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In determining that Velcera acted in concert with Cipla, the
district court relied in part on Velcera's admissions that by
the time of its infringing acts it was aware of the &prime;329
patent, knew PetArmor Plus would infringe the &prime;329 patent
(apart from its subjective belief that the &prime;329 patent
was invalid), and had notice of the 2008 injunction against
Cipla. There is thus little room to dispute that, as it
cooperated with and relied on Cipla in its efforts to bring
PetArmor Plus to market, Velcera was aware of the existing
injunction and understood that acting in concert with Cipla to
market an infringing product (like PetArmor Plus) would violate
the injunction. As to whether Velcera in fact worked in active
concert with Cipla with the common aim of evading the
injunction, Velcera attempts to couch its complaints in terms
of legal error &mdash; that the district court ignored its
independent, arms-length arrangements with Cipla &mdash; but
its argument in reality boils down to disagreement with the
factual conclusions the district court drew from those
relationships. The district court clearly contemplated the
structure of Velcera's interactions with Cipla &mdash; it heard
extensive testimony from Velcera's CEO detailing the
relationships, roles, and specific contractual agreements among
the various players in the PetArmor Plus venture, and the court
recounted those arrangements in the contempt order. The
district court thus appreciated and accepted Velcera's account
regarding the formal legal and business relationships behind
PetArmor Plus; its <span CLASS="page_no" data-cite="2012 bl 132909 p 21" data-cite-type="Bloomberg" data-cite-pageno="21" data-primary-citation="">[***21]</span> view simply diverged from Velcera's
narrative as to the true nature of those relationships: "Clever
lawyers cannot shield the true substance of the contumacious
conduct, no matter how many different entities attempt to
launder Cipla's fingerprints off the product." <i>Contempt</i>
<i>Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *6.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our task on appeal is not to determine whether that factual
conclusion was correct, but rather whether it was clearly
erroneous. <i>Additive Controls II</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X369U3?jcsearch=154%20f%203d%201345&amp;summary=yes#jcite">154 F.3d at 1351</a> ("We review . . . factual findings in contempt proceedings
for clear error."). Conclusive documentary evidence on issues
rooted in subjective intent is not always readily apparent, but
here the district court considered the complex, multilayered
relationships that linked Velcera <span CLASS="page_no" data-cite="103 uspq 2d 1018" data-cite-type="ReporterOfDecisions" data-cite-pageno="1018" data-primary-citation="103 U.S.P.Q.2d 1001">[**1018]</span> and Cipla in the production
of PetArmor Plus. In view of both parties' admitted knowledge
of the injunction and their obvious incentives to evade it, the
district court interpreted those relationships as designed
primarily to obfuscate illicit and intentional concerted action
rather than as bona fide, constructive business arrangements.
Having reviewed the same record, we do not view that conclusion
as clearly erroneous, and Velcera's arguments and self-serving
testimonial evidence to the contrary are insufficient to
persuade us otherwise. Accordingly, we affirm the district
court's decision to hold Velcera in contempt as a non-party
working in active concert with Cipla to violate the 2008
injunction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   VI
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Appellants argue that even if they violated the
district court's
<span CLASS="page_no" data-cite="681 f 3d 1306" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1306" data-primary-citation="681 F.3d 1283">[*1306]</span> 
2008 injunction by bringing PetArmor Plus to market in the
United States, it was nevertheless inappropriate to permanently
enjoin sales of PetArmor Plus in the contempt judgment because,
<i>inter alia</i>, the balance of hardships allegedly weighs
in their favor and Merial allegedly failed to establish
irreparable injury. <i>See eBay Inc. v. MercExchange,</i>
<i>L.L.C.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X151TO4003?jcsearch=547%20us%20388&amp;summary=yes#jcite">547 U.S. 388</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X151TO4003?jcsearch=547%20us%20388&amp;summary=yes#jcite">390</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X151TO4003?jcsearch=126%20supreme%20court%201837&amp;summary=yes#jcite">126 S.Ct. 1837</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X151TO4003?jcsearch=164%20l%20ed%202d%20641&amp;summary=yes#jcite">164 L.Ed.2d 641</a>
(2006).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_917894" href="#headnote_pq2-dec_917894">[12]</a> On the balance of hardships, Velcera contends that the district
court ignored its small size relative to Merial, which, if
properly considered, would tip the balance of hardships in its
favor. While an injunction would have a crippling effect on its
business, Velcera suggests that continued infringing sales of
PetArmor Plus "would not seriously threaten Merial's future."
The district court, however, expressly considered and
ultimately discounted that argument, <a HREF="#fn800" name="fnref_fn800">[fn8]</a> as was properly
within its discretion. As we have noted, "[o]ne who elects to
build a business on a product found to infringe cannot be heard
to complain if an injunction against continuing infringement
destroys the business so elected." <i>Broadcom Corp. v.</i>
<i>Qualcomm Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X19JASI003?jcsearch=543%20f%203d%20683&amp;summary=yes#jcite">543 F.3d 683</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X19JASI003?jcsearch=543%20f%203d%20683&amp;summary=yes#jcite">704</a> (Fed. Cir. 2008); <i>see</i>
<i>also Polaroid Corp. v. Eastman Kodak Co.</i>, <cite>No. 76-1634-Z,</cite>
<cite>1985 U.S. Dist. LEXIS 15003</cite>, at *6, 9 (D.Mass. Oct. 11, 1985)
("To the extent that Kodak has purchased that success at
Polaroid's expense, it has taken a `calculated risk' that it
might infringe existing patents. . . . Public policy favors the
innovator, not the copier."). As to irreparable harm, the
district court concluded that the introduction of PetArmor Plus
as a generic competitor to Frontline Plus would result in
considerable <span CLASS="page_no" data-cite="2012 bl 132909 p 22" data-cite-type="Bloomberg" data-cite-pageno="22" data-primary-citation="">[***22]</span> lost market share and price erosion, thus favoring
the entry of a permanent injunction. That does not amount to
clear error, particularly in view of evidence that Velcera's
marketing strategy was geared specifically to target Frontline
Plus by touting PetArmor Plus as a cheaper but otherwise equal
alternative. We therefore decline to disturb the district
court's injunction against the further infringing distribution
of PetArmor Plus.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               CONCLUSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In sum, we conclude that (1) the 2008 default judgment against
Cipla rested on a valid exercise of personal jurisdiction; (2)
the district court did not abuse its discretion by declining to
stay the contempt proceedings in view of the then-pending
Delaware action; (3) the district court did not clearly err in
determining that PetArmor Plus infringes the &prime;329 patent
and is not more than colorably different from Cipla's
previously enjoined Protektor Plus product; (4) Cipla's
extraterritorial role in the development, production, and
ultimate U.S. sale of PetArmor Plus violated the district
court's injunction against induced infringement of the
&prime;329 patent; (5) Velcera's actions bringing PetArmor Plus
to market in concert with Cipla qualified as contemptuous
conduct despite its status as a non-party to the 2008 default
judgment; and (6) the district court did not abuse its
discretion in prohibiting further sales of PetArmor Plus. We
have considered each of the remaining arguments advanced by the
Appellants and find them to be without merit. Because we find
no reversible error in our review of the contempt proceedings,
we affirm the judgment of the district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>AFFIRMED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> QEDetal LZE is a corporate entity established in the
United Arab Emirates and owned, like QEDetal, by the director
of Omnipharm. J.A. 2227.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The &prime;940 patent, covering fipronil-only pest
control compositions, had expired by the time Merial initiated
the contempt proceedings in March 2011.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> Velcera's declaratory judgment complaint also included
claims of noninfringement and invalidity directed at Merial's
U.S. Patents 6, 620, 943 and 6, 881, 848. Those patents are not
at issue in this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> Soon after the district court entered the <i>Contempt</i>
<i>Order</i>, Velcera's declaratory judgment claims relating to
the &prime;329 patent in the Delaware action were dismissed for
lack of subject matter jurisdiction: "Given the current
injunction [in the Georgia contempt proceedings] and the fact
that Velcera does not have a new, non-enjoined product
containing fipronil and methoprene, there is no actual
controversy between the parties." <i>Velcera Inc. v. Merial</i>
<i>Ltd.</i>, <cite>No. 11-CV-134 (GMS)</cite> (D.Del. Aug. 3, 2011), ECF
No. 38, slip. op. at 4n.4.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> In its analysis, the district court nonetheless treated
three of those shipments as having occurred "during the time
frame surrounding the filing of the Complaint." <i>Contempt</i>
<i>Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> <i>See, e.g.</i>, Br. Def.-Appellant Cipla at 20 ("As
Cipla knew when it received the complaint . . . Merial's
allegations of jurisdiction under the Georgia Long Arm statute
were defective factually and as a matter of law. . . .") .
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> By its terms, the 2008 injunction proscribed both direct
infringement and inducement, banning Cipla from "committing any
act that <i>infringes</i> or <i>causes or induces</i>
infringement of any claim of the &prime;940 or &prime;329
patents." <i>Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *2
(emphases added). Regarding the latter, the terms "induces" and
"causes" are introduced in the alternative, while "causing"
predominates throughout the remainder of the injunction as
prohibited directly and indirectly infringing acts are
alternately enumerated, for example, "using, <i>causing</i>
to be used, selling, <i>causing</i> to be sold, offering for
sale, and <i>causing</i> to be offered for sale . . .
importing and <i>causing</i> to be imported." <i>Id.</i>
(emphases added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> <i>See Contempt Order</i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *15 ("In
this case, the law requires the Court to issue a ruling with
potentially devastating consequences for Velcera. To fail to
follow the law, however, and favor Velcera because of personal
sympathy toward the plight of a fledgling company, would be
exponentially more tragic").
<span CLASS="page_no" data-cite="681 f 3d 1307" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1307" data-primary-citation="681 F.3d 1283">[*1307]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  SCHALL, Circuit Judge, dissenting.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because I believe that the United States District Court for
the Middle District of Georgia erred in not allowing Cipla
Limited ("Cipla") to designate the Northern District of
Illinois as a substitute forum for suit against it, I
respectfully dissent from the decision of the majority
affirming the district court's exercise <span CLASS="page_no" data-cite="103 uspq 2d 1019" data-cite-type="ReporterOfDecisions" data-cite-pageno="1019" data-primary-citation="103 U.S.P.Q.2d 1001">[**1019]</span> of personal
jurisdiction over Cipla. I would reverse the decision of the
court and would vacate the contempt order and underlying
default judgment against Cipla. I also would vacate the
injunction against Cipla, Velcera, Inc. ("Velcera"), and
Fidopharm, Inc. ("Fidopharm"). Finally, I would remand to the
district court with the instruction that it transfer the case
to the United States District Court for the Northern District
of Illinois.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   I.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the district court, Cipla responded to Merial Limited's and
Merial SAS's (collectively, "Merial") motion for contempt by
moving to vacate the 2008 default judgment against it. In its
motion, Cipla argued that the judgment was void because, when
it was entered, Cipla was not subject to the personal
jurisdiction of the court. In response to the motion, Merial
alleged, for the first time, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2</a>) as an alternate basis
for jurisdiction. In ruling on Cipla's motion, although the
district court determined that, in 2008, Cipla had not been
subject to personal jurisdiction under Georgia's long-arm
statute, it determined that Cipla had been subject to personal
<span CLASS="page_no" data-cite="2012 bl 132909 p 23" data-cite-type="Bloomberg" data-cite-pageno="23" data-primary-citation="">[***23]</span> jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2</a>). <i>Contempt Order</i>,
[<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court first noted that, when Cipla was sued in
2007, it did not designate a substitute forum in which the
action could be brought, and that it was not until Cipla filed
its reply in response to Merial's opposition to its motion to
vacate the default judgment that it designated Illinois as a
substitute forum. <i>Id.</i> at *8. Under these
circumstances, the court stated, it was not enough that Cipla
now consented to personal jurisdiction in Illinois. Rather, it
was necessary to determine whether suit could have been brought
in Illinois in 2007:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Court finds that Cipla's "after the fact"
  willingness to consent to jurisdiction in Illinois so
  that it may vacate a previously entered default
  judgment is not sufficient to support a finding that
  it could have been sued in another state and thus
  avoid <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> jurisdiction. Instead the Court
  finds that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> requires a determination of
  whether an Illinois court could have exercised
  personal jurisdiction over Cipla at the time the
  Complaint in this action was filed absent consent to
  jurisdiction by Cipla.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> at *9. <i>See also id.</i> ("The Court finds
that the proper inquiry in a case where a defendant seeks to
avoid a default judgment due to lack of personal jurisdiction
by designating a forum where it is subject to jurisdiction
pursuant to <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> is to determine whether the defaulted
action could have been brought in that designated forum in the
first place under that forum's long-arm jurisdiction.").
Examining what it understood to be the state of Cipla's
contacts with Illinois in 2007, the court concluded that Merial
had carried its burden "of demonstrating that Cipla would not
have been subject to personal jurisdiction in . . . 2007 in
Illinois under Illinois law." <i>Id.</i> Accordingly, the
court found that Cipla "was not subject to any state's courts
of general jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   II.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In affirming the decision of the district court, the majority
observes that it "need not decide . . . the general
requirements for a defendant to prevent the application of
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by consenting to suit in
<span CLASS="page_no" data-cite="681 f 3d 1308" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1308" data-primary-citation="681 F.3d 1283">[*1308]</span> 
another jurisdiction. . . ." Maj. op. at 1295. The majority
states that "it suffices in this case to hold that a defendant,
like Cipla, challenging a prior default judgment may not do so
by naming another forum that would not have had an independent
basis for jurisdiction at the time of the original complaint."
<i>Id.</i> Starting from that premise, the majority agrees
with the district court that, Cipla's consent notwithstanding,
it was necessary to determine whether, in 2007, personal
jurisdiction over Cipla existed under the Illinois long-arm
statute, and the majority finds no error in the district
court's analysis under that statute. Maj. op. at 1294-95.
Significantly, the majority rejects Cipla's argument that it
was entitled to rely on the allegations in Merial's 2007
complaint, which did not mention <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> as a basis for
personal jurisdiction, but, instead, recited jurisdiction based
solely upon Georgia's long-arm statute. Complaint at &para; 14,
<i>Merial Ltd. v. Cipla <span CLASS="page_no" data-cite="2012 bl 132909 p 24" data-cite-type="Bloomberg" data-cite-pageno="24" data-primary-citation="">[***24]</span> Ltd.</i>, No. 3:07-CV-125 (CDL)
(M.D.Ga. Nov. 13, 2007). The majority reasons that
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  [r]egardless of the specific allegations in the 2007
  complaint, Cipla should have apprehended that a
  <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> inquiry might arise, particularly as a foreign
  company believing itself to be outside the reach of
  the forum state's long-arm statute. Furthermore, even
  though Cipla's initial belief that the complaint
  recited an incorrect basis for jurisdiction was
  ultimately vindicated, that issue remained an open
  question at the time, and Cipla had the option of
  filing a pre-answer motion under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L16003?jcsearch=Fed.%20R.%20Civ.%20P.%2012(b)(2)&amp;summary=yes#jcite">Rule 12(b)(2)</a> to
  settle all issues of personal jurisdiction up <span CLASS="page_no" data-cite="103 uspq 2d 1020" data-cite-type="ReporterOfDecisions" data-cite-pageno="1020" data-primary-citation="103 U.S.P.Q.2d 1001">[**1020]</span> front.
  Cipla instead chose to do nothing, and it must bear
  the consequences of that decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Maj. op. at 1297.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                  III.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I am dissenting because, in my view, the majority affirms a
decision of the district court which rests upon two fundamental
errors. As I explain below, I believe that the district court
erred in holding that Cipla could not designate Illinois as a
substitute forum because it had failed to do so in 2007. I also
believe that the district court erred in requiring a
determination that the 2007 action could have been brought in
Illinois in the first place under the Illinois long-arm
statute.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Turning to the first point, I begin with the principle, which
the majority recognizes, that "[a] defendant is always free to
ignore the judicial proceedings, risk a default judgment, and
then challenge that judgment on jurisdictional grounds in a
collateral proceeding." <i>Ins. Corp. of Ireland, Ltd. v.</i>
<i>Compagnie des Bauxites de Guinee</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. 694</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">706</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. 2099</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">2106</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d 492</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">504</a> (1982). <i>See Baragona</i>
<i>v. Kuwait Gulf Link Transp. Co.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1Q6L9K3R9O2?jcsearch=594%20f%203d%20852&amp;summary=yes#jcite">594 F.3d 852</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1Q6L9K3R9O2?jcsearch=594%20f%203d%20852&amp;summary=yes#jcite">854-55</a>
(11th Cir. 2010) (holding that defendants had not waived
personal jurisdiction defense to default judgment despite
allegations of defendants'" `lawyerly gamesmanship' in ignoring
valid service, retaining counsel in the United States, [and]
monitoring court proceedings"); <i>Oldfield v. Pueblo De Bahia</i>
<i>Lora, S.A.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20f%203d%201210&amp;summary=yes#jcite">558 F.3d 1210</a> (11th Cir. 2009) (vacating
default judgment because of lack of personal jurisdiction);
<i>Jackson v. FIE Corp.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XE7CJ8?jcsearch=302%20f%203d%20515&amp;summary=yes#jcite">302 F.3d 515</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XE7CJ8?jcsearch=302%20f%203d%20515&amp;summary=yes#jcite">523</a> (5th Cir. 2002)
("[A] party's right to object to personal jurisdiction is
waived under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L16003?jcsearch=Fed.%20R.%20Civ.%20P.%2012(h)&amp;summary=yes#jcite">Rule 12(h</a>) [of the Federal Rules of Civil
Procedure] if such party fails to assert that objection in his
first pleading or general appearance. But a party's right to
contest personal jurisdiction is not waived by his failure to
appear at all.") (footnote omitted); <i>Foster v. Arletty 3</i>
<i>Sari</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XACDSC?jcsearch=278%20f%203d%20409&amp;summary=yes#jcite">278 F.3d 409</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/XACDSC?jcsearch=278%20f%203d%20409&amp;summary=yes#jcite">413</a> (4th Cir. 2002) (citing <i>Ins.</i>
<i>Corp. of Ireland, Ltd.); Practical Concepts, Inc. v.</i>
<i>Republic</i>
<span CLASS="page_no" data-cite="681 f 3d 1309" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1309" data-primary-citation="681 F.3d 1283">[*1309]</span> 
<i>of Bolivia</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X4AE66?jcsearch=811%20f%202d%201543&amp;summary=yes#jcite">811 F.2d 1543</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X4AE66?jcsearch=811%20f%202d%201543&amp;summary=yes#jcite">1547</a> (D.C. Cir. 1987)
("When [a] person [named as a defendant] kn[o]w[s] about the
action but perceive[s] that the court lack[s] territorial or
subject matter jurisdiction, he is given a right to ignore the
proceeding at his own risk but to suffer no detriment if his
assessment proves correct.") (quoting Restatement (Second) of
Judgments <cite>&sect; 65</cite>, cmt. b (1982)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In my view, for the following reasons, this principle applies
with particular force in this case: (1) Merial at all times had
the burden of making out a <i>prima facie</i> case of
personal jurisdiction over Cipla. <i>See Touchcom, Inc. v.</i>
<i>Bereskin &amp; Parr</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d 1403</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">1410</a> (Fed. Cir. 2009)
(holding that in the absence of an evidentiary <span CLASS="page_no" data-cite="2012 bl 132909 p 25" data-cite-type="Bloomberg" data-cite-pageno="25" data-primary-citation="">[***25]</span> hearing,
plaintiff must make a <i>prima facie</i> showing of personal
jurisdiction); <i>Stubbs v. Wyndham Nassau Resort</i>
<i>&amp; Crystal Palace Casino</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X150OBS003?jcsearch=447%20f%203d%201357&amp;summary=yes#jcite">447 F.3d 1357</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X150OBS003?jcsearch=447%20f%203d%201357&amp;summary=yes#jcite">1360</a> (11th Cir. 2006)
(Plaintiff "has the burden of establishing a prima facie case
of personal jurisdiction.") (citing <i>Meier ex. rel. Meier v.</i>
<i>Sun Int'l Hotels, Ltd.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X4IU5G?jcsearch=288%20f%203d%201264&amp;summary=yes#jcite">288 F.3d 1264</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X4IU5G?jcsearch=288%20f%203d%201264&amp;summary=yes#jcite">1268-69</a> (11th
Cir. 2002)); <i>RAR, Inc. v. Turner Diesel, Ltd.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3AOVB?jcsearch=107%20f%203d%201272&amp;summary=yes#jcite">107 F.3d 1272</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3AOVB?jcsearch=107%20f%203d%201272&amp;summary=yes#jcite">1276</a> (7th Cir. 1997) ("The plaintiff, moreover, has the
burden of demonstrating the existence of personal
jurisdiction."); (2) jurisdiction over Cipla under Georgia's
long-arm statute was the sole basis for personal jurisdiction
asserted by Merial in its 2007 complaint; (3) it has been
determined &mdash; and Merial has not challenged the
determination &mdash; that personal jurisdiction over Cipla did
not lie under Georgia's long-arm statute, which, again, was the
sole basis asserted in the 2007 complaint; and (4) it was not
until Merial filed its response to Cipla's motion to vacate
that Merial invoked <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>, at which point Cipla promptly
designated Illinois as a substitute forum. <i>See</i>
<i>Oldfield</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1AIJV2003?jcsearch=558%20f%203d%201210&amp;summary=yes#jcite">558 F.3d at 1218</a> n. 22 (implicitly recognizing
that, even after a default judgment, an alternative forum may
be identified). I thus believe that the district court erred in
penalizing Cipla for not designating Illinois as a substitute
forum prior to the time <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> was first asserted by
Merial. Put most simply, I believe that because Merial had the
burden of establishing personal jurisdiction and because Cipla
was entitled to ignore what it viewed as a defective basis for
such jurisdiction stated in the 2007 complaint, it was error
not to allow Cipla to designate a substitute forum the first
time <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> was asserted as the ground for personal
jurisdiction over it.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court criticized Cipla &mdash; and the majority
joins in that criticism &mdash; for not having sought to
consent to jurisdiction in the Northern District of Illinois
when it was sued in 2007. Thus, the district court looked
askance at what it characterized as "Cipla's `after the fact'
willingness to consent to jurisdiction in Illinois so that it
may vacate a previously entered default judgment." <i>Contempt</i>
<i>Order<span CLASS="page_no" data-cite="103 uspq 2d 1021" data-cite-type="ReporterOfDecisions" data-cite-pageno="1021" data-primary-citation="103 U.S.P.Q.2d 1001">[**1021]</span> </i>, [<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9. For its part, as noted
above, the majority states that "Cipla should have apprehended
that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> might arise" and that Cipla "had the option
of filing a pre-answer motion under Rule 12(b)(2) to settle all
issues of personal jurisdiction." Maj. Op. at 1297. Finally,
the majority points to <i>Touchcom</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a>, and
states that, in that case, "we held that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> applied
even though it had never been raised at any point prior to
appeal, much less recited as a basis for jurisdiction in the
plaintiffs' original complaint." Maj. op. at 1298.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The difficulty I have with both the district court's and the
majority's position is that, I believe, both positions ignore
what was said in <i>Ins. Corp. of Ireland, Ltd</i>: "A
defendant is always free to ignore the judicial proceedings,
risk a default judgment, and then challenge that judgment on
jurisdictional grounds in a collateral proceeding."
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. at 706</a>,
<span CLASS="page_no" data-cite="681 f 3d 1310" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1310" data-primary-citation="681 F.3d 1283">[*1310]</span> 
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2106</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 504</a>. That is precisely what Cipla did
here. In other words, both the district court and the majority
are critical of Cipla for following a course <span CLASS="page_no" data-cite="2012 bl 132909 p 26" data-cite-type="Bloomberg" data-cite-pageno="26" data-primary-citation="">[***26]</span> of action which
the Supreme Court has expressly stated was available to it. In
my view, this is incorrect.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I also do not agree with the majority's view that "Cipla should
have apprehended that <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> might arise," which, I
think, ignores the allegations in the 2007 complaint. In that
complaint, Merial alleged that the defendants had contacts with
Georgia sufficient to support personal jurisdiction under
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(1)&amp;summary=yes#jcite">Rule 4(k)(1)</a> by virtue of their sales to the state of Georgia.<a HREF="#fn101" name="fnref_fn101">[fn1]</a>
These factual allegations precluded the assertion of personal
jurisdiction under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>, which requires that "the
defendant is not subject to jurisdiction in any state's courts
of general jurisdiction." F.R.C.P. <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)(A)&amp;summary=yes#jcite">4</a>(k)(2)(A). I do not believe
Cipla should have been on notice of the application of
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> when the allegations in the complaint precluded the
application of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the same time, I am not persuaded by the majority's reliance
on Rule 12(b)(2) and its citation to <i>Touchcom.</i> It is
true that Rule 12(b)(2) states that a party "may assert" by
motion the defense of lack of personal jurisdiction. The
critical words are "<i>may assert</i>," however. The rule is
not mandatory. As discussed, Cipla had the option, which it
pursued, of ignoring the 2007 suit in Georgia and later
challenging any default judgment in a collateral proceeding. As
far as <i>Touchcom</i> is concerned, I have no quarrel with
the majority's reading of the case insofar as it indicates that
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> may apply whether or not it is raised by the
parties. But that is not the issue here. I see no error in the
district court having allowed Merial to assert <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> for
the first time in the contempt proceeding. The error I see was
not allowing Cipla, in the face of that assertion, to designate
a substitute forum.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As noted above, the district court stated that "<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>
requires a determination of whether an Illinois court could
have exercised personal jurisdiction over Cipla at the time the
Complaint in this action was filed absent consent to
jurisdiction by Cipla." <i>Contempt Order</i>,
[<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1FJRJQ003?jcsearch=2011%20BL%20163423&amp;summary=yes#jcite">2011 BL 163423</a>], 2011 WL 2489753, at *9. The majority agrees with the district court; it
states:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Contrary to Cipla's contentions, a defendant cannot
  defeat <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by simply naming another state;
  the defendant's burden under the negation requirement
  entails identifying a forum where the plaintiff
  <i>could have</i> brought suit &mdash; a forum where
  jurisdiction would have been proper at the time of
  filing, regardless of consent. Consistent with that
  obligation, a defendant does not identify "a more
  <i>appropriate</i> state" by suggesting an
  alternative form with no basis for personal
  jurisdiction but its consent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Maj. op. at 1294-95. Thus, both the district court and the
majority take the position that, Cipla's consent to
jurisdiction in Illinois notwithstanding, it was necessary to
determine that suit could have been brought in Illinois in the
first place under its long-arm statute. I do not believe that
the law supports this requirement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Touchcom</i>, we stated that "a court is entitled to
use <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> to determine whether it possesses personal
jurisdiction over the defendant unless the defendant names a
state <span CLASS="page_no" data-cite="2012 bl 132909 p 27" data-cite-type="Bloomberg" data-cite-pageno="27" data-primary-citation="">[***27]</span> in which the suit can proceed." <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1414</a>. We then
proceeded to adopt the approach set forth by
<span CLASS="page_no" data-cite="681 f 3d 1311" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1311" data-primary-citation="681 F.3d 1283">[*1311]</span> 
the Seventh Circuit in <i>ISI International, Inc. v.</i>
<i>Borden Ladner Gervais LLP</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d 548</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">551-52</a> (7th
Cir. 2001). There, the court stated:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A defendant who wants to preclude the use of
  <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> has only to name some other state in which the
  suit could proceed. <span CLASS="page_no" data-cite="103 uspq 2d 1022" data-cite-type="ReporterOfDecisions" data-cite-pageno="1022" data-primary-citation="103 U.S.P.Q.2d 1001">[**1022]</span> Naming a more appropriate state
  would amount to a consent to personal jurisdiction
  there (personal jurisdiction unlike federal
  subject-matter jurisdiction is waivable). If, however,
  the defendant contends that he cannot be sued in the
  forum state and refuses to identify any other where
  suit is possible, then the federal court is entitled
  to use <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 552</a> (citations omitted). <i>See Touchcom</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a> ("We conclude that the approach articulated by the
Seventh Circuit is . . . in tune with the purposes behind the
enactment of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>."). <i>See also Bradford Co. v.</i>
<i>Conteyor N. Am., Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1D3MD6003?jcsearch=603%20f%203d%201262&amp;summary=yes#jcite">603 F.3d 1262</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1D3MD6003?jcsearch=603%20f%203d%201262&amp;summary=yes#jcite">1272</a> (Fed. Cir. 2010)
(citing <i>Touchcom</i> and stating that the Federal Circuit
has "adopted the Seventh Circuit's approach that allows a
district court to use <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> whenever a foreign defendant
contends that he cannot be sued in the forum state and
<i>refuses to identify any other state where suit is</i>
<i>possible.</i>") (emphasis added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The reason I disagree with the district court and the majority
is that I am unable to identify any support for imposing the
requirement that, before a party in Cipla's situation may
consent to personal jurisdiction in a substitute forum, it must
be demonstrated that suit could have been brought in that forum
in the first place absent the party's consent. That such
support is lacking is not, I think, surprising. In <i>Ins.</i>
<i>Corp. of Ireland, Ltd.</i>, the Supreme Court discussed the
difference between subject-matter jurisdiction and personal
jurisdiction. After noting that subject-matter jurisdiction is
an Article III requirement and "functions as a restriction on
federal power and contributes to the characterization of the
sovereign[,]" the Court stated that "no action of the parties
can confer subject-matter jurisdiction upon a federal court.
Thus, the consent of the parties is irrelevant."
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. at 702</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2104</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 500-01</a>. On the other
hand, the Court stated, "[t]he requirement that a court have
personal jurisdiction flows not from [Article III] but from the
Due Process Clause. The personal jurisdiction requirement
recognizes and protects an individual liberty interest. It
represents a restriction on judicial power not as a matter of
sovereignty, but as a matter of individual liberty."
<i>Id.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. at 702</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2104</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 501</a> (footnote omitted). The Court concluded that "[b]ecause
the requirement of personal jurisdiction represents first of all an
individual right, it can, like other such rights, be waived."
<i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20U.S.%20694&amp;summary=yes#jcite">Id. at 703</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2105</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 502</a>.
Notably, after making this statement, the Court cited to
<i>McDonald v. Mabee</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5BQLS?jcsearch=243%20us%2090&amp;summary=yes#jcite">243 U.S. 90</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5BQLS?jcsearch=37%20supreme%20court%20343&amp;summary=yes#jcite">37 S.Ct. 343</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5BQLS?jcsearch=61%20l%20ed%20608&amp;summary=yes#jcite">61 L.Ed. 608</a> (1917), where, it stated, "the Court indicated that
regardless of the power of the State to serve process, an
individual may submit to the jurisdiction of the court by
appearance." <i>Id.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. at 703</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2105</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 502</a>. Significantly, in <i>ISI</i>
<i>International</i>, whose approach we have adopted, the court
relied on this aspect of personal jurisdiction when it stated
that "[a] defendant who wants to <span CLASS="page_no" data-cite="2012 bl 132909 p 28" data-cite-type="Bloomberg" data-cite-pageno="28" data-primary-citation="">[***28]</span> preclude use of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>
has only to name some other state in which suit could proceed.
Naming a more appropriate state would amount to a consent to
personal jurisdiction there (personal jurisdiction unlike
federal subject matter jurisdiction is waivable)."
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 552</a>. <i>See, e.g., Bradford</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1D3MD6003?jcsearch=603%20F.3d%201262&amp;summary=yes#jcite">603 F.3d at 1271-2</a> (stating
that jurisdiction may lie over defendant simply by its
acknowledgment in the briefing on appeal that it is subject to
jurisdiction in Michigan); <i>Knowlton v. Allied Van</i>
<span CLASS="page_no" data-cite="681 f 3d 1312" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1312" data-primary-citation="681 F.3d 1283">[*1312]</span> 
<i>Lines, Inc.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3A7MP?jcsearch=900%20f%202d%201196&amp;summary=yes#jcite">900 F.2d 1196</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X3A7MP?jcsearch=900%20f%202d%201196&amp;summary=yes#jcite">1200</a> (8th Cir. 1990)
(stating "consent is a valid basis of personal jurisdiction,
and resort to minimum-contacts or due process analysis to
justify the jurisdiction is unnecessary.") (citing <i>Ins.</i>
<i>Corp. of Ireland, Ltd.</i>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=456%20us%20694&amp;summary=yes#jcite">456 U.S. at 703</a>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=102%20supreme%20court%202099&amp;summary=yes#jcite">102 S.Ct. at 2105</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5CA8Q?jcsearch=72%20l%20ed%202d%20492&amp;summary=yes#jcite">72 L.Ed.2d at 502</a>.); <i>SEC v. Blazon Corp.</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NOCM?jcsearch=609%20f%202d%20960&amp;summary=yes#jcite">609 F.2d 960</a>, <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X2NOCM?jcsearch=609%20f%202d%20960&amp;summary=yes#jcite">965</a> (9th Cir. 1979) ("A defendant cannot waive his
right to assert a lack of subject matter jurisdiction, but he
can confer jurisdiction over his person upon a court otherwise
lacking that jurisdiction by expressly consenting to it."). In
my view, because the rule that allows a party to defeat
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> jurisdiction by designating a substitute forum is
founded upon the proposition that personal jurisdiction is
waivable, it is not necessary to independently establish that
suit could lie in the substitute forum absent the designation.
I thus believe that the district court erred in imposing such a
requirement in this case and that the majority, in turn, errs
in endorsing what the district court did.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I believe the Seventh Circuit's opinion in <i>ISI</i>
<i>International</i> is instructive. There, neither party had
raised the issue of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> before the district court.
<i>ISI, Int'l</i> <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 551</a>. The Seventh Circuit
stated:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  ISI International did not rely on <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>, but S
  &amp; A's appellate lawyer was ready for the questions
  asked during the oral argument. When the court
  inquired whether S &amp; A would be subject to
  personal jurisdiction in any other state (California,
  for example), counsel was noncommittal. <span CLASS="page_no" data-cite="103 uspq 2d 1023" data-cite-type="ReporterOfDecisions" data-cite-pageno="1023" data-primary-citation="103 U.S.P.Q.2d 1001">[**1023]</span> More discovery
  would be needed, counsel suggested. But S &amp; A does
  not need discovery to learn <i>its own acts.</i> Nor
  is it apparent how more facts could contribute to
  resolution of the question. S &amp; A had it within
  its power to knock out <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by agreeing that
  it is subject to personal jurisdiction in some other
  state. It proved unwilling to do so. We there-fore
  conclude that under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> jurisdiction is
  proper in the United States District Court for the
  Northern District of Illinois.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20F.3d%20548&amp;summary=yes#jcite">Id. at 552</a>. Thus, consent to jurisdiction by
defendant's counsel would have been sufficient to defeat
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> jurisdiction.<a HREF="#fn201" name="fnref_fn201">[fn2]</a> The Seventh Circuit rejected the
need for further factual inquiry as the consent of defendant's
counsel was all that was required.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It appears that the majority arrives at its holding based upon
the appearance of the words "could proceed" and "appropriate"
in <i>ISI International, see</i> <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 552</a>, and the
words "could have brought suit" and "suitable" in <i>Touchcom,</i>
<i>see</i> <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a>. Reading the relevant part of its
opinion, <i>see</i> Maj. op. at 1293-94, I understand the
majority to be taking the position that these words support the
requirement that, in this case, there be a showing that suit
could have been brought in Illinois in the first <span CLASS="page_no" data-cite="2012 bl 132909 p 29" data-cite-type="Bloomberg" data-cite-pageno="29" data-primary-citation="">[***29]</span> place. I am
unable to agree. I do not believe that these words, standing
alone, are enough to support engrafting this added requirement
onto the <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> procedure, especially where that
procedure is founded upon the principle that personal
jurisdiction is a matter that is waivable. In addition, I am
unable to reconcile this added requirement with the Seventh
Circuit's statement that the consent of defendant's counsel at
oral argument would have been sufficient to
<span CLASS="page_no" data-cite="681 f 3d 1313" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1313" data-primary-citation="681 F.3d 1283">[*1313]</span> 
"knock out <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>." <i>ISI, Int'l</i>,
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X5103O?jcsearch=256%20f%203d%20548&amp;summary=yes#jcite">256 F.3d at 552</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority also expresses the concern that allowing a party
in Cipla's situation to designate another forum would allow the
party to undo an adverse final judgment and obtain "the chance
to litigate from a clean slate." Maj. op. at 1294-95. The
majority's desire to see litigation brought to a conclusion is
understandable. However, this concern is present in every case
where a default judgment is challenged for lack of personal
jurisdiction. I do not believe this legitimate concern can
trump the requirement that a court have personal jurisdiction
over a defendant and the consequences that result when a
judgment is entered against that defendant in the absence of
such jurisdiction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, allowing Cipla to designate an alternative forum
would aid in bringing this litigation to a conclusion. If this
case were transferred to the Northern District of Illinois,
Cipla would have two options, either respond to the allegations
and fully litigate the dispute or suffer the consequences of a
default judgment. Importantly, Cipla would no longer be able to
challenge a default judgment for lack of personal jurisdiction,
and Merial would have the opportunity to fully press its case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   IV.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the foregoing reasons, I believe that the district court
erred in not allowing Cipla to designate the Northern District
of Illinois as a substitute forum for suit against it. I
therefore would reverse the decision of the court and would
hold that the court lacked personal jurisdiction over Cipla
under <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a>. Consequently, I (1) would vacate the
contempt order and underlying default judgment against Cipla;
(2) would vacate the injunction against Cipla, Velcera, and
Fidopharm; and (3) would remand with the instruction that the
court transfer the case to the Northern District of Illinois.
Accordingly, I respectfully dissent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn101" name="fn101">[fn1]</a></span> Notably, in 2007, Merial elected not to plead the
application of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> in the alternative, as specifically
contemplated by this Court in <i>Touchcom.</i>
<a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1BDS9I003?jcsearch=574%20f%203d%201403&amp;summary=yes#jcite">574 F.3d at 1415</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn201" name="fn201">[fn2]</a></span> The quoted passage also, I believe, contradicts the
assertion of the district court in this case that consent must
occur at the time the complaint is filed. In <i>ISI</i>
<i>International</i>, the question of consent necessarily arose
at a time after the complaint was filed as neither party raised
the issue of <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> before the district court. Thus, the
Seventh Circuit implicitly acknowledges that defendants could
defeat <a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X144L0G003?jcsearch=Fed.%20R.%20Civ.%20P.%204(k)(2)&amp;summary=yes#jcite">Rule 4(k)(2)</a> by consenting to jurisdiction elsewhere at
some time after the complaint was filed.
</p></div>
<!--BBLS DD 1710824226819-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HPAH4003/history">Direct History (10)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HPAH4003/analysis">Case Analysis (32)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HPAH4003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
32
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Veterinary Medicine</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1Q6LS580R82">11-01471 (Fed. Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/bd5ce10409fb087e0c3197a78cab0775/document/X1Q6LS581BO2">11-01472 (Fed. Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Civil Procedure</div><div class='facetItemLabel'>Copyright Law</div><div class='facetItemLabel'>Damages &amp; Remedies</div><div class='facetItemLabel'>Patent Law</div><div class='facetItemLabel'>Trademark Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/bd5ce10409fb087e0c3197a78cab0775/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "bd5ce10409fb087e0c3197a78cab0775";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5db653&previousPageId=&previousActivityInstanceId=ENTITY7e9486&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:52:05-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HPAH4003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY7e9486&previousPageId=&previousActivityInstanceId=ENTITY52c4a6&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:52:02-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HPAH4003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HPAH4003";
$('#page_loader').show().spin();
JUDGE_IDS=["1718421","1840120","4283465"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
